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ABSTRACT 
 
 
 
PROCESSING OF 3′-BLOCKED DNA DOUBLE-STRAND BREAKS BY TYROSYL-DNA 
PHOSPHODIESTERASE 1, ARTEMIS AND POLYNUCLEOTIDE KINASE/ 
PHOSPHATASE 
 
Ajinkya Kawale, MS 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2018. 
 
Advisor: Dr. Lawrence F. Povirk, Professor, Department of Pharmacology and Toxicology 
 
 
 
DNA double-strand breaks (DSBs) containing unligatable termini are potent cytotoxic 
lesions leading to growth arrest or cell death. The Artemis nuclease and tyrosyl-DNA 
phosphodiesterase (TDP1) are each capable of resolving protruding 3′-phosphoglycolate (PG) 
termini of DNA double-strand breaks (DSBs). Consequently, a knockout of Artemis and a 
knockout/knockdown of TDP1 rendered cells sensitive to the radiomimetic agent neocarzinostatin 
(NCS), which induces 3′-PG-terminated DSBs.  Unexpectedly, however, a knockdown or 
knockout of TDP1 in Artemis-null cells did not confer any greater sensitivity than either deficiency 
xix 
 
 
alone, indicating a strict epistasis between TDP1 and Artemis.  Moreover, a deficiency in Artemis, 
but not TDP1, resulted in a fraction of unrepaired DSBs, which were assessed as 53BP1 foci.  
Conversely, a deficiency in TDP1, but not Artemis, resulted in a dramatic increase in dicentric 
chromosomes following NCS treatment.  An inhibitor of DNA-dependent protein kinase, a key 
regulator of the classical nonhomologous end joining (C-NHEJ) pathway sensitized cells to NCS 
but eliminated the sensitizing effects of both TDP1 and Artemis deficiencies. Moreover, 
Polynucleotide Kinase/ Phosphatase (PNKP) is known to process 3′-phosphates and 5′-hydroxyls 
during DSB repair. PNKP-deficiency sensitized both HCT116 and HeLa cells to 3′-phosphate 
ended DSBs formed upon radiation and radiomimetic drug treatment. The increased cytotoxicity 
in the absence of PNKP was synonymous with persistent, un-rejoined 3′-phosphate-ended DSBs. 
However, DNA-PK deficiency sensitized PNKP-/- cells to low doses of NCS suggesting that, in 
the absence of PNKP, alternative enzyme(s) can remove 3′-phosphates in a DNA-PK-dependent 
manner. These results suggest that TDP1 and Artemis perform different functions in the repair of 
terminally blocked DSBs by the C-NHEJ pathway, and that whereas an Artemis deficiency 
prevents end joining of some DSBs, a TDP1 deficiency tends to promote DSB mis-joining. In 
addition, loss of PNKP significantly sensitizes cells to 3′-phosphate-ended DSBs due to a defect 
in 3′-dephosphorylation. 
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1. GENERAL INTRODUCTION 
 
 
 
 
1.1 Structure of DNA 
The discovery of the double-helical structure of DNA was arguably one of the most 
important breakthroughs that revolutionized biology forever. Linus Pauling, a pioneer and the 
world’s best physical chemist at that time, had just discovered the single-stranded alpha helical 
structure found in proteins and had diverted his attention to the elucidating the structure of DNA 
and was at the pole position to finding it out. Pauling soon proposed a tripe helix model of DNA 
that surprisingly had the bases orienting outwards and the phosphates facing the interior! Soon, it 
was realized that the like negative charges on the phosphates would repel them and it became 
apparent that his structure was incorrect.  
On April 25th 1953, in their seminal paper, James Watson and Francis Crick laid out the 
molecular structure of nucleic acids (WATSON & CRICK, 1953). The structure of DNA described 
by Watson and Crick, who were greatly helped by Rosalind Franklin and Maurice Wilkins, had a 
double-helix with the phosphates pointing outwards unlike the triple helix put forth by Pauling. 
The two helical chains are comprised of the sugar phosphate backbone that run antiparallel to one 
another. 
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The bases are oriented on the inside of the helix allowing them to hydrogen bond with the 
corresponding bases on the opposite strand holding the two strands together by purine and 
pyrimidine bases. The purines (Adenine and Guanine) always pair with their Pyrimidine 
counterparts (Thymine and Cytosine respectively). The intra-strand distance between each base is 
3.4 A. One helical turn of DNA has 10 bases and is thus, 34 A long whereas the distance between 
the two strands is 20 A. For their discovery of the structure of DNA, James Watson, Francis Crick 
and Maurice Wilkins were awarded the Nobel Prize in Physiology and Medicine in 1962. At the 
end of their seminal paper, Watson and Crick made an interesting comment that opened up new 
avenues for researchers leading to the proposal of not only the basic central dogma of molecular 
biology comprising of DNA replication, transcription and translation but also other DNA 
metabolic processes like DNA repair and recombination.  
 
“It has not escaped our notice that the specific pairing we have postulated 
immediately suggests a possible copying mechanism for the genetic material.” 
 - Jim Watson & Francis Crick, Nature 1953. 
 
1.2 Historical Perspective on DNA repair 
Damaged DNA can be repaired by different types of distinct mechanisms that differ 
drastically from one another. It is believed that the process of enzymatic photoreactivation (EPR) 
is the first DNA repair mechanism that evolved in nature. When life was evolving in the primordial 
soup, one can imagine the important role this process would have played in protecting the DNA 
of these early organisms from the harmful UV radiation coming from the sun. Incidentally, EPR 
was also the first DNA repair mechanism to be discovered independently by two American groups 
in the 1940s, almost a decade prior to the discovery of the structure of DNA (Friedberg, 2008; 
Friedberg, 2015).  
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Following the discovery of penicillin, Albert Kelner, working at the Cold Spring Harbor 
Laboratory, was attempting to identify strains of Streptomyces that produced new and more 
efficacious antibiotics. In an attempt to standardize his experimental system, Kelner was trying to 
mutagenize E. coli and Streptomyces cells growing on agar plates by exposing them to different 
doses of UV radiation. To his great dissatisfaction, he regularly obtained extremely irreproducible 
survival yields. In a letter to one of his friends, Kelner confided his frustration: 
“My first task was to irradiate E. coli with UV light to induce mutants, and from 
the first experiment in October 1946 I ran into difficulty with the reproducibility 
of survival rates…… I would irradiate a suspension, assay an aliquot for survival, 
storing the remainder of the suspension at 5 °C until the assay plates grew…….  I 
needed a suspension of irradiated cells whose titer was accurate to about +/− 25% 
colonies per plate. But irradiation with the same UV dose two days apart gave 
variations exceeding this limit……… By October or November of 1946, I had 
acquired a healthy disrespect for the implications of quantitative exactness of the 
beautiful UV survival curves in the literature.” 
   
-Albert Kelner in a letter to Claude Stanley Rupert, 14 years after his experiments 
(Friedberg, 2008) 
 
Little did he know, he was onto something spectacular. Upon further examination, Kelner 
found out the source of his variable results was exposure to fluorescent lights in the laboratory and 
also further demonstrated that exposure of cells to visible light considerably rescued the viability 
of UV-irradiated cells. 
While Kelner was trying to find an explanation to his enigmatic observations, around 800 
miles away at University of Indiana - Bloomington, Renato Dulbecco, a postdoc in the lab of 
Salvadore Luria, was trying to study bacteriophage replication. While attempting to mutagenize 
phage-infected cells using UV-radiation, Dulbecco observed a great variation in the surviving 
fraction of phages obtained from the stacks of agar plates stored on his bench. Quite smartly, he 
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noticed that plates from top of the stacks showed the greatest number of plaques formed by the 
phages. An excerpt from the letter written by Lurio to Kelner describing Dulbecco’s findings is 
provided below: 
“Dulbecco ran into photoreactivation in a most queer way, by forgetting to put off 
the fluorescent light on a table on which he left a pile of plates with irradiated 
phage to incubate them at room temperature. Next day the top plate had 100× 
more plaques than the bottom one, and the intermediate ones had gradually 
different numbers…… It is a most exciting thing, and I imagine that the bacterial 
phenomenon you discovered must also be such.” 
 
- Salvadore Luria in a note to Albert Kelner (Friedberg, 2008) 
 
Like Kelner, Dulbecco too realized the presence of a light-dependent mechanism of DNA 
repair. These serendipitous discoveries led to the identification of the photoreactivation process 
and was later demonstrated to be catalyzed by a light-dependent photoreactivating enzyme. 
Interestingly, a young graduate student by the name of James Watson was one of Dulbecco’s 
colleagues who went on to demonstrate that photoreactivation was not observed when cells were 
exposed to ionizing radiation instead of UV radiation (Friedberg, 2008).  
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Figure 1-1 Albert Kelner (Left) and Renato Dulbecco (Right) 
Adapted from (Friedberg, 2008) 
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1.3 Double strand breaks – most lethal of all DNA lesions  
Since the identification of DNA as the genetic material followed by the discovery of its 
structure almost 65 years ago, astute investigations have revealed the presence of complex 
mechanisms that preserve the genetic message encoded by DNA. These remarkable mechanisms 
protect the integrity of the genome by rapid and efficient repair of the damage induced to DNA 
and thus, warrant accurate transmission of genetic information over many generations.  
Spontaneous endogenous damage constitutes DNA alterations brought about by mis-
incorporation of nucleotides during DNA replication, modification of bases by alkylation or 
deamination, abasic lesions formed due to depurination and oxidation of bases and single- and 
double-strand breaks as a result of reactive oxygen species (ROS) formed during normal cell 
metabolism (Chapman, Taylor, & Boulton, 2012). Exogenous DNA damage can be induced by 
various physical and chemical sources. Ultraviolet radiation (UV-B) from sunlight is estimated to 
induce almost 105 pyrimidine dimers or photoproducts per cell per day (Ciccia & Elledge, 2010). 
Ionizing radiation is extremely heterogenous and produces a large number of strand breaks in 
addition to base damage. The list of chemical agents inducing DNA damage is nearly limitless and 
includes a variety of drugs used in cancer chemotherapy such as alkylating agents (temozolomide), 
crosslinking agents (platinum drugs), topoisomerase poisons, radiomimetic drugs, etc.  
In contrast to other DNA lesions, DSBs are the most threatening as their defining feature 
is a physical disruption of the molecular continuity of DNA. The frequency with which DSBs are 
induced by exogenous sources of radiation is especially very high. Interesting statistical values 
help put this fact into perspective. Assuming that mammalian cells irradiated with 1 Gy accumulate 
around 40 DSBs per cell and ~1000 SSBs per cell, an approximately 20-hour flight from Mumbai, 
India to Richmond, Virginia results in around 0.004 DSBs per cell, a full body CT scan leads to 
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around 0.3 DSBs per cell, a 2-month space mission results in around 2 DSBs per cell, the 
Chernobyl incident resulted in around 12 DSBs per cell, external beam radiotherapy results in 
around 80 DSBs per cell (Ciccia & Elledge, 2010).  
However, the potentially lethal damage that DSBs can cause is perhaps more alarming than 
their sheer numbers. If DSBs are left unrepaired, all the genetic material between the breaks and 
the telomeres could be potentially lost during mitosis. This could result in large deletions in 
chromosomes resulting in daughter cells devoid of critical genetic regions and cause cell death. If 
DSBs are inappropriately repaired, it can cause large sequential alterations and lead to 
chromosomal aberrations including inversions, deletions and translocations by illegitimate joining 
of wrong pair of DSBs ends (Deriano & Roth, 2013). The deletions can lead to inactivation of 
critical tumor suppressor genes leading to neoplastic transformation. Chromosomal translocations 
can result in gene fusion activating oncogenes and causing transformation of normal cells into 
cancer cells. A study conducted 10 years ago suggested that gene fusions accounted for around 
20% of human cancer morbidity (Mitelman, Johansson, & Mertens, 2007).  Given the lethality of 
DSBs, it is extremely essential for cells to be effectively armored against these lethal lesions. 
Fortunately, cells have evolved highly orchestrated and complex network of responses to deal with 
DSBs referred to as the DNA damage response (DDR).  
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Figure 1-2: DNA Damage response (top) and 53BP1 recruitment at DSB sites (bottom) 
The DNA damage response is elicited upon DSB formation that includes a whole host of proteins 
taking part in different activities ultimately recruiting the effector protein 53BP1. (Panier & 
Boulton, 2014; Sulli, Di Micco, & d'Adda di Fagagna, 2012) 
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Figure 1-3: Double-strand break repair pathways 
DSB induction leads to the activation of DSB repair pathways. Depending on the cell cycle 
phase and recruitment of certain proteins, specific pathways are activated. cNHEJ is the most 
dominant pathway active throughout the cell cycle that functions with minima if any resection. If 
the break is resected, it leads to the channeling of the DSBs to either HR, SSA or A-EJ.  
(Ceccaldi, Rondinelli, & D'Andrea, 2016) 
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Figure 1-4: Non-Homologous End Joining Pathway Schematic 
Upon DSB induction, Ku70/80 immediately binds to the DSB ends and channels the DSBs 
towards NHEJ. It recruits other proteins in NHEJ including DNA-PKcs, XRCC4/Ligase IV and 
XLF. This leads to the bridging of DNA ends via a filament mediated by XRCC4 and XLF.  
Nucleases and polymerases may also be recruited to the DSB sites to process the modified ends. 
Once the ends have been made ligatable, Ligase IV in association with XRCC4 ligates the ends 
resealing the break.  (Davis & Chen, 2013)  
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1.4 DNA damage response 
For any effective repair system, high sensitivity allowing the rapid detection of even a 
single lesion is paramount. The DDR is an answer for the high sensitivity detection of DSBs and 
elicits an orchestrated response downstream for their accurate repair. The DDR is mediated by 
three key protein belonging to the phosphoinositol-3-kinase-like protein kinases (PIKKs); Ataxia-
Telangiectasia Mutated (ATM), ATM and Rad3-related (ATR) and DNA-dependent Protein 
Kinase (DNA-PK) (Blackford & Jackson, 2017). In addition, Poly (ADP-ribose) polymerase 
(PARP) family members also play crucial roles in the sensing of DSBs (Price & D'Andrea, 2013). 
While ATM and DNA-PK are activated in response to DSBs, ATR is activated in response to 
single-stranded DNA formation at stalled replication forks or at end-resection steps during 
homologous recombination.  
ATM is a serine/threonine kinase which is recruited and activated by the Mre11-Rad50-
Nbs1 (MRN) complex at DSB sites (Paull, 2015). Once activated, ATM phosphorylates a plethora 
of substrate proteins important in DNA repair, cell cycle regulation, transcription and chromatin 
remodeling among many other processes. A central player in the DNA damage response is the 
tumor suppressor protein p53. Upon DSB formation, ATM phosphorylates and activates the 
Checkpoint effector Kinase 2 (Chk2) which then phosphorylates p53. p53 is also phosphorylated 
directly by ATM and once activated, promotes arrest of cell cycle progression until the damage is 
repaired (Blackford & Jackson, 2017).  
Another key substrate of ATM is the histone variant H2AX. ATM phosphorylates H2AX 
at the serine 139 position referred to as γ-H2AX over megabase regions surrounding a DSB site. 
This is an extremely quick response that starts within a minute and peaks by 20 minutes upon DSB 
formation (Rogakou, Pilch, Orr, Ivanova, & Bonner, 1998). This phosphorylation is a critical event 
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that signals the physical location of the DSB to the DNA repair machinery. γ-H2AX (pS139) is 
recognized by mediator of DNA-damage checkpoint protein 1 (MDC1) which is also 
phosphorylated by ATM leading to the recruitment of the E3-ubiquitin ligase RNF8. RNF8 
mediates the recruitment of RNF168 which ubiquitylates histone H2A on lysine 13/15 
(H2AK13/K15). The ubiquitylation of H2AK15 leads to the stable recruitment of oligomerized 
p53-binding protein 1 (53BP1) which also needs mono- and dimethylated H4K20 (Panier & 
Boulton, 2014). Recruitment of 53BP1 is a defining crossroad in channeling DSB repair to one of 
the two dominant pathways. 53BP1 is phosphorylated by ATM that recruits RIF1. Presence of 
53BP1-RIF1 complex channels the DSBs to repair by a rapid, but somewhat error prone pathway 
called the Non-Homologous End Joining pathway that promotes direct ligation of the DSB ends 
with minimal processing. However, a cell cycle dependent influence of BRCA1 at these sites 
specifically in S-G2 phase antagonizes the 53BP1-RIF1 complex and promotes DNA end-
resection via Mre11 and C-terminal binding protein-interacting protein (CtIP) committing to the 
more accurate but slower Homologous Recombination Repair pathway (Escribano-Diaz et al., 
2013).  
1.5 Double-strand break repair pathways 
Given the harmful nature of DSBs, it is perhaps unsurprising that the cell has devoted so 
many resources for their repair. In mammalian cells, DSBs are most commonly repaired by two 
well-known pathways; Non-Homologous End Joining and Homologous Recombination repair 
(Davis & Chen, 2013). In the absence of these major pathways, other backup repair systems like 
the Alternative End Joining (A-EJ, also referred to as Microhomology-mediated end joining, 
PARP1-dependent end joining, Pol θ-mediated end joining in the DNA repair lexicon), single-
strand annealing (SSA) and synthesis-dependent strand annealing (SDSA) are used (Ceccaldi et 
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al., 2016). The backup systems are relatively less understood but are considered to be more 
dangerous at the same time. However, it is important to note that these backup systems are really 
subtypes of the two main repair pathways mentioned above and can takeover in the absence of the 
canonical factors.  
1.6 Non-Homologous End Joining (NHEJ) 
NHEJ is the major pathway DSB repair pathway that is active throughout the cell cycle 
and is the only major pathway functioning in the G0/G1 phase. As the name suggests, this pathway 
does not need a homologous template and promotes direct end joining of two adjacent non-
homologous ends across a DSB. Apart from repairing pathological DSBs induced by ionizing 
radiation, radiomimetic drugs or other chemotherapeutic agents, NHEJ is also critical for repairing 
physiological DSBs generated during the V(D)J and Class switch recombination processes during 
B- and T-lymphocyte maturation (Lieber, 2010). An interesting aspect of NHEJ is its ability to 
accept a diversity of substrates and convert them to joined products. This demands a great 
flexibility in mechanical interaction of involved proteins to accept a plethora of different substrates 
that are generally produced following exposure to free radicals. Reactive oxygen species can 
interact with DNA to produce multiply damaged sites with different lengths of overhangs, end 
termini blocked with oxidation products and several types of base damage most commonly 8-
oxoguanine and thymine glycols. These variously modified overhangs are joined by NHEJ 
regardless of the sequence, overhang length or DNA end products. Although, the process looks 
deceitfully naïve and guileless, in actuality, it is an incredibly intricate, orchestrated process 
involving a variety of proteins performing highly specific functions in order to achieve the aim of 
repairing these deleterious DSBs. 
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NHEJ can be arbitrarily divided into 3 major steps: A) DNA end recognition, assembly and 
bridging; B) DNA end processing (if required) and C) DNA end ligation (Davis & Chen, 2013). 
Immediately upon DSB formation, the ring-shaped heterodimer Ku70/Ku80 (hereafter referred to 
as Ku) recognizes and rapidly binds to the DSB ends initiating the NHEJ repair pathway. Ku then 
recruits DNA-PKcs (DNA-dependent protein kinase catalytic subunit) and together they form the 
DNA-PK core complex resulting in activation of the kinase activity of DNA-PK. If the DSB ends 
are modified/ unligatable, an arsenal of end processing enzymes is available to the cell to process 
the ends and make them ligatable. These proteins include the nucleases like Artemis, 
Polynucleotide Kinase/ Phosphatase, Tyrosyl-DNA Phosphodiesterase 1 and 2 (TDP1/TDP2), 
Aprataxin and PNKP-like factor (APLF) and the polymerases μ and λ. The terminal step involves 
direct ligation of the broken DNA ends by DNA Ligase IV in association with XRCC4 and XLF 
(Sishc & Davis, 2017). Improper regulation of the end processing steps in NHEJ can potentially 
lead to insertions or deletions in the DNA sequence and thus, NHEJ is often termed as error-prone. 
The three steps are outlined in more detail below.  
1.6.1 DSB recognition and complex assembly 
Ku is highly abundant in cells with concentrations of 4-5 X 105 molecules of Ku per cell 
and it has an extraordinarily high affinity for DNA ends with equilibrium constant in the nanomolar 
range allowing it to immediately localize to DSBs (Lieber, Ma, Pannicke, & Schwarz, 2003). X-
Ray Crystallography studies have revealed that the structure of Ku is ring-shaped which fits the 
DNA perfectly inside it, allowing it to slide onto the DNA strands. Recruitment of Ku also has 
been linked with aligning of the DNA strands, maintaining their stability and protecting them from 
non-specific degradation. Upon recruitment, Ku acts as a scaffolding platform and mediates 
recruitment of several other NHEJ proteins including DNA-PKcs, XRCC4, Ligase IV, XLF. APLF 
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and TDP1. Upon recruitment of DNA-PKcs, Ku translocates inwards allowing DNA-PKcs to 
contact the terminal ~10bp (Davis & Chen, 2013). Atomic force Microscopy studies show that 
DNA-PKcs molecules on each end of a DSB form a bridge between the two ends ultimately leading 
to the formation of a synaptic complex involving DNA ends, Ku and DNA-PKcs (Lieber et al., 
2003). The kinase activity of DNA-PK is critical and a number of NHEJ proteins are substrates of 
DNA-PK. DNA-PK phosphorylates Artemis and activates its endonuclease function. DNA-PK 
also phosphorylates XRCC4 and XLF and this is thought to promote the dissociation of the 
complex upon ligation (Deriano & Roth, 2013). 
1.6.2 DSB end-processing 
Complex ends formed by ionizing radiation or reactive oxygen species possess chemical 
modifications and are unligatable. These incompatible termini thus, have to be processed before 
the ends can be rendered ligatable. Auto-phosphorylation of DNA-PKcs results in the DNA ends 
being accessible to the end-processing nucleases and polymerases. Most of the end processing 
enzymes are recruited to the DSB ends via the Ku-XRCC4 scaffold (Sishc & Davis, 2017). Artemis 
is a key enzyme that possesses and intrinsic 5′-3′ exonuclease function but acquires an 
endonuclease activity upon phosphorylation by DNA-PKcs allowing it to trim many DNA 
substrates irrespective of the end blocking groups (Lieber, 2010). PNKP, a bifunctional enzyme 
recruited by an interaction with XRCC4/Ligase IV complex, processes both 3′-phosphate- and 5′-
hydroxyl-ended DSBs (Weinfeld, Mani, Abdou, Aceytuno, & Glover, 2011). 3′-phosphoglycolate 
residues formed upon radiation or radiomimetic drug treatment can be biochemically removed by 
TDP1 or APE1 (Kawale & Povirk, 2018). The nature of the break also dictates whether the 
polymerases are needed to fill-in gaps at these DSB ends. Polymerases μ and λ function in NHEJ 
by interacting with Ku via their N-terminal BRCT domains. In the presence of Ku and 
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XRCC4/Ligase IV, Pol μ can polymerize in a template-independent manner. Although these 
polymerases are ubiquitous, primary cells from pol μ and λ knockout mice do not show sensitivity 
to IR (H. H. Y. Chang, Pannunzio, Adachi, & Lieber, 2017).  
1.6.3 DNA end-ligation 
The final stage in the repair of DSBs through the NHEJ pathway involves gap filling 
followed by ligation of the DNA ends that have been aligned, tethered and processed by making 
them ligatable. DNA Ligase IV is the principal ligase in NHEJ and in association with XRCC4, 
forms the central component of mammalian NHEJ. Cells deficient in either proteins show dramatic 
sensitivity to radiation. Mice deficient in XRCC4 or Ligase IV are embryonically lethal.  XRCC4 
stimulates Ligase IV activity by promoting adenylation of Ligase IV. XRCC4 and XLF form 
alternating filaments that enable synapsis and bridging of the DNA ends (Menon & Povirk, 2017). 
XLF is also essential for gap filling by the polymerases μ and λ and is believed to play a role in 
aligning the two ends prior to ligation (Akopiants et al., 2009). APLF is believed to aid in ligation 
in the presence of Ku (Hammel et al., 2016).  
At one-ended DSBs formed upon replication, the nuclease activities of MRN complex 
counteract Ku and release a DNA fragment bound to Ku thereby eliminating Ku from DNA ends 
(Chanut, Britton, Coates, Jackson, & Calsou, 2016). However, at regular two-ended DSBs, owing 
to the stability of Ku on the DNA ends, it could theoretically be trapped onto DNA after ligation 
of DSB ends. Evidence suggests that Ku removal from DSB ends is directed via its ubiquitination. 
Ku80 K48 is polyubiquitylated by Skp1-Cul1-Fbxl12 resulting in degradation of Ku by the 
proteasome (Postow & Funabiki, 2013). RNF8 was also thought to promote Ku dissociation as 
depletion of RNF8 prolonged retention of Ku at laser-induced DSBs (Feng & Chen, 2012).  
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1.7 Radiomimetic Agents 
The idea of treating cancer through chemotherapy brought forth many anti-tumor 
antibiotics that target the DNA by inducing DNA damage (Dedon & Goldberg, 1992). These 
chemical agents induce free-radical based single- as well as double-strand breaks in the DNA 
molecule by attacking the deoxyribose moieties in the DNA phosphodiester backbone. Since their 
effects mimic that of ionizing radiation, these chemotherapeutic agents are termed as radiomimetic 
drugs. Although the action of these radiomimetic agents is highly specific, forming lesions which 
represent a subset of the lesions generated due to IR, the effect of IR and radiomimetic agents on 
cells is surprisingly similar. Significant work has been published on some radiomimetic drugs like 
Bleomycin, Neocarzinostatin and Calicheamicin. Bleomycins are a family of glycopeptides first 
isolated from Streptomyces verticillus by Umezawa and colleagues in 1966 (Umezawa, Maeda, 
Takeuchi, & Okami, 1966). Since their discovery, the bleomycins have been an important 
component in a number of combination chemotherapy protocols against testicular cancer (Einhorn, 
2002) and certain types of lymphoma (Bayer, Gaynor, & Fisher, 1992; J. Chen & Stubbe, 2005).  
Neocarzinostatin and Calicheamicin are compounds which belong to the bicyclic enediyne 
family of anti-tumor antibiotics and are amongst the most studied of the radiomimetic drugs. These 
agents have a 10-membered characteristic unsaturated core containing two acetylenic groups 
conjugated to a double bond. These drugs are unique for their potential to produce sequence 
specific double stranded lesions which transpire due to the action of carbon-centered radicals of a 
single drug molecule (Dedon & Goldberg, 1992). Treatment of DNA with NCS in presence of 
Glutathione led to formation of double strand breaks in a very high proportion with the ratio of 
single strand lesions: double strand lesions being around 2:1. The reaction of DNA with 
Calicheamicin was even more potent producing single strand lesions: double strand lesion ratio of 
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around 1:20 (Chaudhry, Dedon, Wilson, Demple, & Weinfeld, 1999). Both bleomycin and the 
enediyne neocarzinostatin (NCS) are potent clastogens, and they can also induce, in various 
systems, base substitutions small deletions, large-scale gene rearrangements, with reasonable 
efficiencies. That these mutations seem to so rarely result in carcinogenesis is certainly one of the 
most intriguing aspects of the genetic toxicology of these agents (Povirk, 1996).  
 
1.7.1 Neocarzinostatin (NCS)  
NCS was the first of the bicyclic enediyne antibiotics that was discovered. It was isolated 
from the bacterial species Streptomyces carzinostaticus. It was recognized as a simple antitumor 
antibiotic protein competent in inhibiting DNA synthesis and inducing the degradation of DNA in 
cells. However, only 15 years after its discovery it was realized that the true biological function of 
NCS was not due to the protein but rather to a previously unrecognized tightly, but non-covalently, 
bound labile non-protein chromophore (NCS-Chrom). The apoprotein contains a hydrophobic 
cleft where NCS-Chrom is believed to reside and is protected from degradation. The structure of 
NCS can be divided into 3 domains, the naphthoate region which serves as the DNA binding 
domain, the enediyne core which form the DNA-damaging machinery and cyclic carbonate 
structure responsible for uptake of the drug in the cells (Dedon, P., & Goldberg, I. 1992).  
The interaction of NCS with DNA has been extensively characterised. The drug binds to 
the DNA in a two-step process involving external binding followed by the intercalation of the 
chromophore. Electric dichroism studies have shown that the naphthoate acts as a classic 
intercalator, orienting itself parallel to the DNA bases which causes a distortion of the DNA helix 
(Dasgupta, D & Goldberg, I. H. 1985; Povirk, L. F. 1996) This leads to the positioning of the active 
enediyne portion of the NCS-chromophore in the minor groove of the DNA molecule with 
favourable electrostatic interactions between the positively charged amino sugar in NCS and the 
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negatively charged Phosphodiester backbone. This binding of the drug in the minor groove is 
evident from 2 sources: Modification of the major groove did not alter the binding constant of 
NCS whereas Netropsin and distamycin, two minor groove binding agents competed with NCS 
for binding to DNA (Dasgupta, D., and Goldberg, I. H. 1985).  
Mechanism of Action 
The mechanism of action of NCS and the damage caused by it is highly complex. NCS-
mediated DNA damage results in the formation of single as well as double strand breaks. Similar 
to all radiomimetic drugs, its mechanism of action is based on the hydrogen atom abstraction 
principally at the 1st, 4th and 5th carbon of the deoxyribose sugar leading to its oxidation (Povirk 
and Steighner. 1989). The identity of these hydrogen atoms abstracted have been verified using 
isotope labelling studies (Dedon, P., & Goldberg, I. 1992). Abstraction of the hydrogen from the 
C-5ʹ end is the characteristic trait of the enediyne compounds resulting in the formation of a 3ʹ-
phosphate and a 5ʹ-aldehyde molecule at the DNA terminus (Kappen et al., 1982). A small subset 
of breaks also involves 3ʹ- and 5ʹ- phosphates at the termini as well. This hydrogen abstraction 
from the 5th carbon of the deoxyribose sugar followed by the incorporation of oxygen into the 
aldehyde leads to the production of single strand breaks in the DNA strands.  
In contrast to the above mechanism, hydrogen abstraction from both C-1ʹ and C-4ʹ leads to 
the formation of bi-stranded lesions. Elimination of the C-1ʹ hydrogen by NCS mainly results in 
the formation of an abasic site in the form of 2ʹ-deoxyribonolactone. This species is quite unstable 
in alkali and ultimately leads to the formation of a strand break with 3ʹ- and 5ʹ-phosphate termini. 
(Povirk and Houlgrave, 1988; Povirk et al. 1988). NCS mediated attack at C-4ʹ adds oxygen at C-
4ʹ ultimately leading to the production of strand breaks with ends containing 3ʹ-phosphoglycolates 
and 5ʹ-phosphates with the formation of a base, propenal (Chaudhry, M. et al 1999). 
 20 
 
1.7.2 Calicheamicin  
The calicheamicins are produced by the fermentation of Micromonospora echinospora ssp 
calichensis, a bacterium isolated from a chalky, or caliche, soil sample collected in Texas. They 
were discovered in the mid- 1980s in a fermentation products screening program through the use 
of the biochemical induction assay (BIA), which utilized a genetically engineered strain of 
Escherichia coli to detect DNA damaging agents (Lee, M. et al 1991). Calicheamicin and 
Esperamicin lack intercalating moieties and thus bind to DNA by other means than NCS. The 
carbohydrate side chains of Calicheamicin serve as a DNA binding domain. The DNA damaging 
element present in Calicheamicin is similar to NCS consisting of a highly strained ring system 
with a pair of triply unsaturated carbon bonds surrounding a carbon-carbon double bond (Lee, M. 
et al 1991).  
The nature of DNA damage instigated by Calicheamicin has not been as extensively 
studied as some of the other enediynes like NCS. However, it is known to produce both single as 
well as double strand lesions with an astoundingly high proportion of double strand lesions 
(Dedon, P., & Goldberg, I. 1992). 
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Figure 1-5: Structures of enediyne antitumor antibiotics - Calicheamicin (Top) and 
Neocarzinostatin (bottom) 
Adapted from (Dedon & Goldberg, 1992) 
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Figure 1-6: Mechanism of NCS action and typical DSB ends formed 
NCS mediated hydrogen atom abstraction can take place from 1ʹ, 4ʹ or 5ʹ carbon of the 
deoxyribose sugar. 5ʹ-H abstraction followed by oxidation leads to the production of 3ʹ-
phosphate and a nucleoside 5ʹ-aldehyde in presence of thiols whereas in absence of thiols, 3ʹ-
formyl-phosphate and 5ʹ-phosphate are formed. 1ʹ-H abstraction leads to the formation of an 
abasic site and a 2-deoxyribonolactone. 4ʹ-H abstraction, in presence of thiols, leads to the 
formation of a 4ʹ-hydroxylated abasic site whereas in the absence of thiols, 3ʹ-phosphoglycolate 
and a 5ʹ-phosphate with the release of the base propenal. Adapted from (Dedon & Goldberg, 
1992)  
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Figure 1-7: NCS and CAL induced bistranded lesions with specific modifications 
NCS and CAL have been shown to produce two types of bistranded lesions: At the 
AGT.ACT sequence, bistranded lesions consists of mainly C4ʹ -hydrogen abstraction at the T of 
AGT, as suggested by the presence of 3ʹ-phosphoglycolate residues and 4ʹ -hydroxylated abasic 
sites, and C5ʹ-aldehyde at the T of ACT. Adapted from (Dedon & Goldberg, 1992) 
  
 24 
 
2. INTRODUCTION TO THE THESIS 
 
 
 
2.1 Tyrosyl-DNA Phosphodiesterase 1 (TDP1) 
The double-helical structure of DNA is paramount for the storage of genetic information 
and its transmission through DNA metabolic processes such as replication, transcription, 
recombination and chromatin remodeling. Local unwinding of DNA induced by these DNA 
metabolic processes causes supercoiling of DNA leading to topological entanglements that need 
to be untangled in order to maintain cellular function and genomic stability. Fortunately, cells have 
evolved special, highly conserved biological tools called topoisomerases to resolve these genomic 
entanglements. 
For example, Topoisomerase 1 regulates DNA topology using a cleavage-religation 
mechanism in which transient single-strand breaks (SSBs) induced in the DNA, link Top 1 to the 
3′-DNA end via an active site tyrosine residue (Y723) (Ashour, Atteya, & El-Khamisy, 2015). 
This leads to the formation of a DNA-Top 1 covalent intermediate commonly referred as Top 1 
cleavage-complexes (Top1cc) (Pommier, 2013). Normally, this intermediate is briskly religated, 
relaxing the supercoiled DNA. However, presence of modifications in the DNA such as abasic 
sites, nicks or gaps, mismatches, modified bases, nucleotide analogs and almost all kinds of DNA 
lesions as well as topoisomerase poisons like camptothecin interferes with the ligation reaction
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and result in trapped covalent DNA-enzyme intermediates (D. Davies, Interthal, Champoux, & 
Hol, 2002). Consequently, these trapped covalent complexes pose a risk to the integrity of the 
genome and need to be processed.  
2.1.1 Discovery 
In 1996, it was serendipitously observed that an oligonucleotide bearing a phosphotyrosine 
residue at the 3′-end was processed in an unpredicted manner upon its incubation with extracts of 
several eukaryotic cells (Yang et al., 1996). Treatment of the substrate resulted in the formation of 
product with mobility similar to that expected from the hydrolytic loss of terminal tyrosine. The 
specificity of this tyrosyl-DNA phosphodiesterase activity, its conservation across a range of 
eukaryotic species and the fact that 3′-phosphotyrosyl (3′-pTyr) substrates mimic trapped Top 1 
cleavage complexes suggested that this enzyme might be a part of the pathway for the repair of 
Top1cc (Yang et al., 1996).  Subsequently, the Saccharomyces cerevisiae gene encoding TDP1 
was isolated by random mutagenesis and screening of clones for loss of TDP1 activity. TDP1-
defective mutants were found to be hypersensitive to camptothecin (CPT), an anticancer 
chemotherapeutic drug that specifically traps Top 1, further drawing attention to its role in the 
repair of Top1cc (Pouliot, Yao, Robertson, & Nash, 1999). The human gene for TDP1 was soon 
cloned and it was found by mutational and sequence analysis that TDP1 was a member of the 
phospholipase D (PLD) superfamily (Interthal, Pouliot, & Champoux, 2001). Subsequent work 
established the crystal structure of TDP1 and the mechanism of its action (D. Davies et al., 2002). 
Shortly after, it was determined by linkage analysis, physical mapping and a positional candidate 
gene approach in a Saudi Arabian family that mutation in TDP1, and thereby a deficiency in 
repairing the stalled Topoisomerase I complexes, caused an extremely rare genetic disease 
Spinocerebellar Ataxia with Axonal Neuropathy (SCAN1) (Takashima et al., 2002). With the 
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TDP1 gene cloned and its crystal structure solved, new avenues opened allowing researchers to 
investigate the biochemistry and the molecular biology of a previously-challenging niche of DNA 
repair.  
2.1.2 Structure  
Human tyrosyl-DNA phosphodiesterase 1 is a predominantly nuclear protein comprising 
608 amino acids with a molecular weight of 68.5kDa. The protein can be subdivided into two 
domains – an N terminal regulatory domain extending up to amino acid 148 and a C-terminal 
catalytic domain extending from 149 to 608 (D. Davies et al., 2002). The N-terminal domain is 
dispensable for the catalytic function but is important for the recruitment of TDP1 to the sites of 
damaged chromatin. Indeed, an N-terminal deletion mutant (Δ1-148) of human TDP1 (hTDP1) in 
vitro retained wild type levels of processing of the Top 1 peptide from the 3′ end of an 
oligonucleotide substrate (Interthal et al., 2001). Sequence alignments of TDP1 orthologs from 
different species have demonstrated that TDP1 represents a unique subclass within the PLD 
superfamily of proteins. The uniqueness of TDP1 and its orthologs is attributed to the two ‘HKN’ 
catalytic motifs instead of the characteristic HKD motifs found in the other members of the PLD 
superfamily. Each of the sequence motifs contain a highly conserved histidine, lysine and 
asparagine (H263, K265 and N283 in the N-terminal motif and H493, K495 and N516 in the C-
terminal motif). Site-directed mutagenesis established that both H263 and H493 are the key 
catalytic residues as H263A, H493A and H493N mutants were 10000X, 3000X and 15000X less 
active than the wild-type protein (Interthal et al., 2001). The other conserved residues in the ‘HKN’ 
motifs K265, N283, K495 and N516 are key for substrate binding and the stabilization of the 
transition state (D. R. Davies, Interthal, Champoux, & Hol, 2003). These two HKN motifs together 
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make up the active site at the bottom and near the center of the protein allowing it to function as a 
monomer.  
2.1.3 Catalytic Mechanism 
TDP1 catalyzes the removal of tyrosyl-peptide from the DNA in a two-step ʹping pongʹ-
type phosphoryl transfer reaction via a covalent phosphoenzyme intermediate (Gottlin, Rudolph, 
Zhao, Matthews, & Dixon, 1998). The first step involves a nucleophilic attack on the tyrosyl-DNA 
3ʹ-phosphate by the imidazole N2 atom of H263 of the N-terminal HKN motif. H493 of the C-
terminal HKN motif acts as a general acid catalyst to protonate the tyrosyl moiety of the departing 
Top 1 peptide. This results in the formation of the covalent intermediate in which the cleaved 
substrate is temporarily linked to TDP1. In the second step, H493 acts as a general base catalyst 
and activates a water molecule which subsequently hydrolyzes the phosphoenzyme intermediate 
(Interthal et al., 2005). This leads to the release of 3ʹ-phosphate ended DNA which is converted by 
polynucleotide kinase/ phosphatase (PNKP) into 3ʹ-OH DNA.  A missense mutation in the TDP1 
gene (A1478G) causing a substitution of H493 with an arginine residue is the genetic basis behind 
the pathology of an extremely rare autosomal recessive neurodegenerative disorder, 
Spinocerebellar Ataxia with Axonal Neuropathy (SCAN1) characterized by ataxia, cerebellar 
atrophy and peripheral neuropathy. TDP1 H493R mutant manifests around 25X decreased rate of 
hydrolysis of the tyrosyl-containing peptide from the DNA and ironically itself becomes 
covalently trapped with a relatively long half-life of around 13 min (Interthal et al., 2005). The 
autosomal recessive nature of the disease suggests that WT TDP1 can resolve the mutant TDP1-
DNA covalent complexes.  
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Figure 2-1: Structure of TDP1 
(A) Domain structure of human TDP1. Sites shown in blue are key residues in the active site of 
TDP1. (B) Critical TDP1-substrate interactions in the TDP1 active site. Crystal structure of 
TDP1 (1NOP) obtained from Protein Data Bank (PDB) website was used to generate a model of 
the TDP1 active site in complex with the DNA substrate and the Top I peptide using Cn3D. 
Amino acids in the active site are represented as sticks and color-coded. DNA substrate is shown 
in red. 3′-phosphotyrosyl bond is indicated as a dashed line between 3′ end of the substrate and 
Y703 and highlighted. Top I peptide is shown in light orange. (C and D) Surface representation 
of TDP1 substrate binding channel was generated using Chem3D on crystal structure of TDP1 
(1JY1) obtained from PDB (C) Front view and (D) Top view of the substrate binding channel 
with the DNA and peptide binding regions highlighted (Kawale & Povirk, 2018). 
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Figure 2-2: Catalytic mechanism of TDP1 in its canonical function 
(A) Nucleophilic attack on the tyrosyl–DNA 3′-phosphate by the imidazole N2 atom of H263. 
H493 donates a proton to the outgoing Top I peptide. (B) Formation of the TDP1-DNA covalent 
intermediate. (C) H493 activates a water molecule which attacks the 3′-P breaking the N-P bond 
and hydrolyzing the phosphoenzyme intermediate. (D) Release of DNA 3′-phosphate from TDP1 
(Kawale & Povirk, 2018). 
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2.1.4 Role in SSB repair 
TDP1 was initially described as a clean phosphodiesterase activity that explicitly removed 
a tyrosyl containing peptide from a DNA end leaving a 3ʹ-phosphate and was shown to be critical 
for the repair of TopIcc (Pouliot et al., 1999). Consequently, TDP1 deficient cells are 
hypersensitive to CPT and its clinical derivative irinotecan (Meisenberg et al., 2015; Miao et al., 
2006). On the other hand, as observed by single cell gel electrophoresis experiments, HEK293 
cells overexpressing WT but not mutant TDP1H263A exhibit significantly reduced DNA damage 
induced by CPT (Barthelmes et al., 2004). To date, TDP1 remains one of the very few enzymes 
that specifically remove a 3ʹ-block from the DNA end without actually resecting the DNA by even 
a single base (Interthal, Chen, & Champoux, 2005). Although it shows a weak activity in removing 
a normal nucleoside from a 3′ DNA end, the inability of TDP1 to act on the resulting 3′-P terminus 
prevents TDP1 from functioning as a general 3ʹ-exonuclease. For this reason, activity of TDP1 in 
the removal of 3′-phosphotyrosyl residues in human cells is coupled with a specific DNA 3ʹ-
phosphatase, PNKP, to generate 3′-OH, which can then be readily acted upon by DNA 
polymerases and ligases (Weinfeld et al., 2011). 
The sensitivity of TDP1-deficient cells to Top 1 poisons was initially hypothesized to be 
specific to cells in the DNA synthesis phase where collision of approaching replication forks with 
TopIcc would lead to the formation of DSBs. However, TDP1’s involvement in the pathology of 
SCAN1, a disease of terminally differentiated post-mitotic neurons, and the fact that SCAN1 cells 
show hypersensitivity to Top 1 poisons led to the emergence of a new question: Why does TDP1 
mutation and Top 1 poisoning kill post-mitotic neurons, cells that do not enter S-phase? An 
explanation to this discrepancy was provided when it was shown that sensitivity of SCAN1 cells 
to CPT was abrogated by DRB (5,6-dichloro-1-β-D-ribofuranosylbenzimidazole), a transcription 
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inhibitor, but not by aphidicolin, a replication inhibitor suggesting that SCAN1 cells are defective 
for the repair of transcription-induced Top1cc (Miao et al., 2006). In addition, these transcription-
induced cleavage complexes cause the formation of transcription-dependent DSBs after Top 1 
proteolysis prior to TDP1’s action leading to the activation of the DNA damage response via ATM 
and DNA-PK and that these co-transcriptional DSBs kill quiescent cells (Cristini et al., 2016). 
Thus, the highly elevated transcription rates and increased oxygen demands in neuronal cells 
lacking TDP1 produce increased levels of unrepaired Top1cc and oxidative damage due to 
enhanced topoisomerase activity providing molecular insights in the pathogenesis of SCAN1. 
TDP1 eliminates 3ʹ-phosphoglycolate ends both in vitro and in cells formed as a result of 
oxidative DNA damage although the efficiency of this processing is hundred times less than that 
of its canonical 3ʹ-pTyr substrate (Hawkins et al., 2009; Zhou et al., 2005). SCAN1 cells are 
defective in repairing IR-induced SSBs (El-Khamisy, Hartsuiker, & Caldecott, 2007). The 
alkylating agent methyl methane sulfonate (MMS) produces N7-methyl guanine adducts which 
are processed by DNA N-glycosylases/AP lyases to form abasic (AP) sites and 3ʹ-deoxyribose 
phosphate (3ʹ-dRP) ends (Murai et al., 2012). Tdp1-/- DT40 chicken cells and human TDP1 
knockdown (KD) cells show hypersensitivity to alkylating agent MMS and this sensitivity can be 
almost fully averted by complementing with human TDP1. Additional depletion of APE1 in TDP1 
KD cells enhances the hypersensitivity of these cells to MMS (Alagoz, Wells, & El-Khamisy, 
2014). Thus, these results suggest involvement of TDP1 in the base excision repair pathway (BER) 
in removing abasic sites independently of APE1.  
Chain terminating nucleoside analogs (CTNAs) lack a 3ʹ-OH group and thus block DNA 
synthesis after getting incorporated in DNA. These CTNAs are extensively used as anti-viral and 
anti-cancer agents specially in treating HIV and adult T-cell leukemia (ATL). TDP1 repairs 
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nuclear and mitochondrial DNA damage induced by CTNAs including acyclovir (ACV), 
cytarabine (Ara-C), zidovudine (AZT) and zalcitabine (ddC) (Huang et al., 2013). Tdp1-/- DT40 
and mouse embryonic fibroblast (MEF) cells are hypersensitive to ACV and Ara-C and show 
enhanced depletion of mitochondrial DNA in response to AZT and ddC. ATL cells are deficient 
in TDP1-dependent repair and are thus selectively killed by anti-HIV drug Abacavir (ABC) (Tada 
et al., 2015). Very recently, in the first published evidence of successful inactivation of the human 
TDP1 by genetic manipulation, it has been shown that Tdp1-/- HCT116 and TSCER2 cells display 
enhanced sensitivity to CNDAC, an analog of Ara-C further underscoring the importance of TDP1 
in the repair of CTNA-induced DNA damage (Abo et al., 2017). 
2.1.5 Regulation of TDP1   
The biology of TDP1 is elegantly regulated by its interactions with other DNA repair 
factors and post-translational modifications (PTMs) including poly ADP-ribosylation 
(PARylation), phosphorylation and sumoylation. The N-terminal region of TDP1, which is 
dispensible for catalytic function, is the target for these modifications. Thus, these PTMs do not 
play a role in enhancing the catalytic function of the protein but merely increase stabilization and 
recruitment to the sites of DNA damage.  
Poly (ADP-Ribose) Polymerase 1 (PARP1) is a highly conserved multifunctional enzyme 
that catalyzes the polymerization of ADP-ribose moieties derived from NAD+ onto itself or other 
target proteins (Rouleau, Patel, Hendzel, Kaufmann, & Poirier, 2010). PARP1 and TDP1 are 
epistatic for the repair of TopIcc as TDP1-/-.PARP1-/- double mutant DT40 avian cells show similar 
sensitivity to CPT as their single mutant counterparts (Das et al., 2014). C-terminal region of 
PARP1 binds the N-terminal region of TDP1 and poly ADP-ribosylates (PARylates) TDP1 
without inhibiting its catalytic activity and promotes its recruitment to TopIcc-induced DNA 
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damage sites. Micro-irradiation with live-cell microscopy and biochemical analysis show that 
PARylation of TDP1 promotes the recruitment of both itself and XRCC1 to the sites of Top1-
induced DNA damage and leads to the stabilization of TDP1 in response to Top1cc-induced DNA 
damage (Das et al., 2014).  
In human cells, TDP1 is phosphorylated at serine 81 by ATM and DNA-PK following 
ionizing radiation and CPT treatment (Das et al., 2009). As this site is located in the N-terminal 
region which is dispensable for enzyme activity, phosphomutants show no difference in enzymatic 
activity in yeast in vitro (Chiang, Carroll, & El-Khamisy, 2010). However, pS81-TDP1 forms 
nuclear foci that co-localize with γH2AX foci which presumably are sites where TopI induced 
SSBs are converted to DSBs following replication fork collision (Das et al., 2009). In addition, 
phosphorylation of TDP1 is important for its stabilization and promotes binding to XRCC1 and 
Ligase IIIα as seen from co-immunoprecipitation and immunofluorescence microscopy (Chiang et 
al., 2010). XRCC1 is a scaffolding protein that interacts with several BER factors and is also 
known to play a role in the repair of TopIcc presumably by recruiting TDP1 and PNKP (Plo et al., 
2003). The interaction of TDP1 with Ligase IIIα also likely contributes to mitochondrial BER 
(Tomkinson & Sallmyr, 2013).   
2.1.6 TDP1 in DSB repair 
The biochemical competency of TDP1 in the resolution of glycolate ends first suggested 
the possible involvement of TDP1 in the repair of DSBs bearing terminally-occluded 3ʹ-overhangs 
(Inamdar et al., 2002). Tdp1-/- MEF extracts are completely inept in removing protruding 3′-
phosphoglycolate termini from similar substrates suggesting that, in extracts, the processing of 
DSBs with protruding 3′-PG termini is entirely dependent on TDP1 (Hawkins et al., 2009). Tdp1-
/- mice and Tdp1-/- DT40 chicken cells both show hypersensitivity to bleomycin (Murai et al., 
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2012). Whole cell extracts (WCEs) from lymphoblastoid cells derived from SCAN1 patients are 
deficient in catalyzing the conversion of 3ʹ-PG termini on 3ʹ-overhanging model DSB substrates 
in vitro with no measurable processing for several hours (Zhou et al., 2005). In comparison, normal 
cells from unaffected relatives show substantial processing within a few minutes. Treatment with 
calicheamicin leads to increased chromosomal aberrations in SCAN1 cells, particularly dicentric 
chromosomes suggesting that absence of TDP1 leads to mis-joining of DSB ends (Zhou et al., 
2009).  
In yeast, TDP1 has been shown to be an accessory component of the Non-Homologous 
End Joining (NHEJ) pathway (Bahmed, Nitiss, & Nitiss, 2010). Clean DSB ends generated by 
linearizing plasmid substrates with restriction enzymes are mis-repaired leading to inaccurate 
repair joints with insertions in the absence of TDP1. Additional deletion of yeast NHEJ proteins 
like Ku and Ligase IV does not increase the frequency of mis-repair suggesting that yTDP1 
promotes repair fidelity in the context of NHEJ (Bahmed et al., 2010). Furthermore, human TDP1 
has been suggested to play a role in the early stages of mammalian NHEJ by promoting the 
assembly of NHEJ protein complexes on DNA (Heo et al., 2015). TDP1 associates with the NHEJ 
protein complexes by directly interacting with XLF and Ku70/80. This contrasts with other end-
processing factors like PNKP, APLF and Aprataxin that play a role in NHEJ by interacting with 
XRCC4. XLF stimulates activity of TDP1 on dsDNA. Additionally, TDP1 promotes DNA binding 
by Ku70/80 and stimulates the kinase activity of DNA-PK (Heo et al., 2015). Furthermore, it was 
recently reported that TDP1 was required for efficient NHEJ in human cells as HEK293 cells 
deficient in TDP1 showed an increase in insertions at I-SceI-induced DSB repair joints (J. Li, 
Summerlin, Nitiss, Nitiss, & Hanakahi, 2017). Finally, TDP1 has also been shown to play a role 
in the repair of etoposide-generated DSBs (Borda, Palmitelli, Veron, Gonzalez-Cid, & de Campos 
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Nebel, 2015). Human TDP1-knockdown (Tdp1kd) cells are hypersensitive to etoposide and show 
increased number of chromosomal breaks and mis-joining events which are further enhanced by 
DNA-PK depletion. However, equal number of Rad51 foci and sister-chromatid exchanges in WT 
and Tdp1kd cells suggest that depletion of TDP1 disrupts classical as well as the alternative end 
joining pathways but not HR for the repair of TopIIcc (Borda et al., 2015). Thus, taken together, 
these results present persuasive evidence for the involvement of TDP1 in DSB repair (Kawale & 
Povirk, 2018). 
2.2 Artemis 
2.2.1 Discovery 
Immunoglobulins produced by lymphocytes are important molecules of the humoral 
immune system for the neutralization of foreign antigens. The antigen-binding region of these 
immunoglobulins is encoded by the variable (V), diversity (D) and joining (J) gene segments that 
recombine through a mechanism known as V(D)J recombination (Roth, 2014). The V, D and J 
segments are each flanked by recombination signal sequences (RSS). The process of V(D)J 
recombination begins with the introduction of a double-strand break by specialized nucleases 
known as RAG1 and RAG2 upon recognition of the RSS. Induction of a DSB is accompanied by 
hairpin sealed coding ends that need to be opened. This leads to the activation of the NHEJ repair 
pathway requiring the Ku70/80-DNA-PKcs complex. DNA-PK activity is essential for opening of 
the hairpin ends (S. H. Lee & Kim, 2002). Along these lines, a defect in the V(D)J recombination 
process was observed in patients suffering from severe combined immunodeficiency (SCID) 
owing to an early arrest of both B and T cell maturation. Mutations in RAG1 or RAG2 genes were 
observed in a subset of patients with SCID (Schwarz et al., 1996).  
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However, in other patients, a V(D)J recombination defect was often accompanied by an 
increased sensitivity to ionizing radiation (RS-SCID) and was not caused by mutations RAG1 or 
RAG2, DNA-PKcs or other V(D)J proteins mentioned above (Cavazzana-Calvo et al., 1993; 
Nicolas et al., 1998). This suggested that the defect in V(D)J recombination in these patients was 
characterized by a defective gene encoding a novel undescribed factor. Moshous and colleagues, 
first identified and cloned this novel factor defective in human radiosensitive - severe combined 
immunodeficiency (RS-SCID) (Moshous et al., 2001). In classical Greek mythology, Artemis was 
the goddess of protecting young children and as this condition was lethal within the first year of 
life of young children, the protein was named Artemis. 
The gene encoding Artemis is DNA Cross-Link Repair 1C (DCLRE1C). Athabascan SCID 
or RS-SCID is a highly rare, autosomal recessive inherited disease which is characterized by early 
onset of severe opportunistic infections with severe oral and genital ulcers. Affected children 
generally die from these infections within six months without a bone-marrow transplant (L. Li et 
al., 2002). A unique, autosomal recessive non-sense mutation in exon 8 of DCLRE1C gene leading 
to the truncation of the protein product at the 192nd amino acid was also shown to cause SCID in 
Athabascan-speaking Native Americans (L. Li et al., 2002).  
2.2.2 Structure 
Artemis is a 78 kDa protein, encoded on p arm of chromosome 10, belonging to the 
metallo-β-lactamase family consisting of 692 amino acids. Two domains in its N-terminus, a 
metallo-β-lactamase domain, spanning amino acids 1-155 and a β-CASP domain spanning amino 
acids 156-385, have been shown to be important for the catalytic activity of Artemis (Callebaut, 
Moshous, Mornon, & de Villartay, 2002). The β-CASP domain is highly conserved in other 
proteins belonging to the same family that specifically act on nucleic acids. Like all proteins 
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belonging to metallo-β-lactamase superfamily, Artemis also needs divalent cations, specifically 
Mg+2, to be catalytically active (Pannicke et al., 2004). The active site of Artemis contains 4 
Histidine residues and 4 Aspartic acid residues which are highly conserved between Artemis and 
other metallo-β-lactamase proteins. These active site histidines and aspartates are thought to co-
ordinate metal ions for a nucleolytic attack onto the DNA (Pannicke et al., 2004). Thus, the N-
terminal region of Artemis is the catalytic region for the Artemis protein. The regulatory C-
terminal region of Artemis is predicted to be unstructured and has been shown to be important for 
the interaction with DNA-PKcs and Ligase IV. Specifically, residues 399-403 which are adjacent 
to the nuclease domain interact with DNA-PKcs whereas residues 485-495 interact with Ligase 
IV (Niewolik et al., 2006). DNA-PKcs phosphorylates Artemis in its C-terminal region and causes 
a conformational change resulting in its activation. 
2.2.3 Biochemical properties 
Artemis possesses a single-strand DNA (ssDNA)-specific 5′-3′ exonuclease activity but 
acquires an endonuclease activity upon phosphorylation by and association with DNA-PK (Ma, 
Schwarz, & Lieber, 2005). The endonuclease function is important during the process of V(D)J 
recombination for the opening of hairpin DNA ends as well as for the trimming of 3′- and 5′-
overhangs on DSB ends during the NHEJ repair pathway (Ma, Pannicke, Schwarz, & Lieber, 
2002). This endonucleolytic trimming completely eliminates 5′-overhangs whereas the 3′-
overhangs are only shortened to 2-3 nts upon prolonged incubation. Artemis is biochemically 
competent in processing 3′-phosphoglycolate overhangs into 3′-hydroxyl ends in an ATP- and 
DNA-PK-dependent manner, suggesting its involvement in repairing unligatable modified DSB 
via NHEJ (Povirk, Zhou, Zhou, Cowan, & Yannone, 2007). The 5′-3′ exonuclease function of 
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Artemis is unlikely to play a role during NHEJ as this activity is suppressed by DNA-PK at DSB 
ends.  
Although WT Artemis demonstrates 5′-3′ exonuclease activity, its endonucleolytic 
function is absent in vitro. In contrast to WT Artemis however, C-terminal deletion mutants of 
Artemis (Artemis without the C-terminal region) exhibit endonucleolytic hairpin opening activity 
in vitro. This suggested that the C-terminal domain of Artemis performs a regulatory role 
(Niewolik et al., 2006). Studies performed to elucidate this function indeed showed that a physical 
interaction between the N-terminal catalytic domain and the C-terminal region mediates 
autoinhibition of Artemis (Niewolik, Peter, Butscher, & Schwarz, 2017).  
Initially, Artemis was shown to be catalytically active on hairpin- and overhanging 
substrates. However, it is now known that Artemis is effective on a wide range of DNA structures 
albeit weakly, including blunt ends and ssDNA-dsDNA transitions. Artemis resects AT-rich, but 
not GC-rich blunt ends via a DNA end-breathing step in a manner dependent on both Ku and 
DNA-PKcs (H. H. Chang, Watanabe, & Lieber, 2015). Recently, a physical model describing the 
key contact points of Artemis•DNA-PKcs with their known DNA substrates was developed (H. 
Chang H.Y. & Lieber, 2016). According to this model, Artemis•DNA-PKcs contacts the DNA 
substrate at 3 positions; 2 contact points are located right at the dsDNA-ssDNA boundary one on 
each strand and the third point (which is the catalytic site) is located one nucleotide on the 5′-end 
of point B. This model proposed that without these contact points, the activity of Artemis•DNA-
PKcs was negligible. This model also explains the differential function of Artemis on 3′- and 5′-
overhangs.  
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2.2.4 Function in DSB repair 
Cells deficient in NHEJ proteins including DNA-PK show intensive radiosensitivity as do 
Artemis-defective cells, thus giving evidence to the requirement of Artemis in the NHEJ pathway 
for the repair of DSBs. Ionizing radiation, and radiomimetic drugs like Neocarzinostatin (NCS) 
create chemically modified, unligatable DSB ends like 3ʹ-phosphates and 3ʹ-phosphoglycolates. 
As Artemis deficient cells are sensitive to IR, it was postulated that Artemis could mediate the 
end-processing of these chemically modified termini. Indeed, biochemical analysis have shown 
that Artemis in association with DNA-PKcs can convert such unligatable ends to a form that is 
appropriate for ligation with a minimal loss of the terminal nucleotides. ATM hyperphosphorylates 
Artemis in response to IR treatment and thus ATM is required for Artemis-dependent processing 
of damaged DNA ends. ATM, however, is not required for V(D)J recombination activity of 
Artemis as A-T cells deficient in ATM are proficient in V(D)J recombination (Jeggo & Lobrich, 
2005). 
Moreover, Artemis-deficient CJ179 fibroblasts from SCID patients show increased 
sensitivity to radiation, NCS and bleomycin compared to normal cells (Mohapatra, Kawahara, 
Khan, Yannone, & Povirk, 2011). Artemis is required for the repair of a subset of IR-induced 
DSBs as observed from an increased persistence of γ-H2AX foci in cells deficient in Artemis and 
for this function, Artemis and ATM are epistatic (Riballo et al., 2004). Interestingly, Artemis and 
ATM were also shown to promote homologous recombination of IR-induced DSBs in the G2 
phase of the cell cycle. The endonuclease function of Artemis was shown to be important for 
resecting DSBs leading to the formation of ssDNA and Rad51 foci at these DSBs in G2 (Beucher 
et al., 2009). In contrast, only ATM and not Artemis is required for HR-mediated repair of IR-
induced DSBs in S-phase (Kocher et al., 2012).   
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More recently, novel roles of Artemis have come to light. Artemis associates with PTIP in 
mediating repair pathway choice by acting as a major downstream effector of 53BP1 limiting end 
resection and promoting NHEJ (J. Wang et al., 2014). Quite surprisingly, Artemis mediates DNA 
double-strand break resection in G1 phase via a slow repair component involving classical NHEJ. 
This process requires CtIP interacting with BRCA1 to initiate resection, Mre11 exonuclease 
activity, EXD2 and Exo1 execute the process and the endonuclease function of Artemis completes 
the process (Biehs et al., 2017).   
Apart from its end-processing function, Artemis also plays a role in the DNA damage 
signaling. (Kurosawa & Adachi, 2010). Artemis is phosphorylated by ATM and in response to 
ionizing radiation, is needed for recovery from the G2/M cell cycle checkpoint by regulation of 
Cdk1-Cyclin B (Geng, Zhang, Zheng, & Legerski, 2007). Artemis was shown to be 
phosphorylated by ATR at Ser516 and Ser645 in response to replication stress leading to 
ubiquitination and degradation of cyclin E, thus promoting recovery from S-phase checkpoint (H. 
Wang, Zhang, Geng, Teng, & Legerski, 2009).  
2.3 Polynucleotide Kinase/ Phosphatase 
Eukaryotic polynucleotide kinases (PNK) were identified in the early 1960s and were 
observed to function similar to the T4 phage counterparts in specifically phosphorylating 5′-
hydroxyl termini on DNA and RNA oligonucleotides. Subsequently, this enzyme was also shown 
to possess a 3′-phosphatase activity in addition to the 5′-kinase function (Pheiffer & Zimmerman, 
1982). Several years later, the human PNKP gene was cloned and was identified as one of the two 
known mammalian DNA 3′-phosphatase along with the previously described weak 3′-phosphatase 
APE/HAP1 (Jilani et al., 1999). Since then, extensive research has been carried out on this 
bifunctional enzyme and has been shown to play a critical role in DNA SSB as well as DSB repair.  
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2.3.1 Structure 
Based on amino acid sequence conservation and secondary structure predictions, the PNKP 
protein can be divided into 2 distinct domains; an N-terminal forkhead associated (FHA) domain 
and a C-terminal catalytic domain comprising of the phosphatase and kinase sub-domains fused to 
each other. The FHA domain is important for the interaction of PNKP with other DNA repair 
factors such as XRCC1 (in SSB repair) and XRCC4 (in NHEJ). Although a crystal structure of a 
full length human PNKP is not available, that of the murine PNKP has revealed several key aspects 
of the protein.  
The phosphatase sub-domain (136 – 337 amino acids) belongs to haloacid dehalogenase 
(HAD) superfamily of proteins whose activity is dependent on Mg+2 and a catalytic aspartate 
residue. Unlike the TDP1-mediated reaction, which proceeds via a phosphohistidine intermediate, 
PNKP reactions proceed via a phosphoacyl intermediate. The phosphatase active site is narrow 
and cannot accommodate a double-stranded DNA suggesting of a DNA end-breathing step prior 
to phosphatase activity on blunt- or recessed-end DNA substrates. The kinase sub-domain (340 – 
521 amino acids) belongs to the P-loop kinase family and has separate ATP and DNA-binding 
sites. Unlike the phosphatase domain cleft, the active site cleft in the kinase domain is able to 
accommodate SSB as well as DSB substrates owing to a wide recognition groove composed of 2 
positively charged surfaces (Weinfeld et al., 2011).   
2.3.2 Function 
Owing to its bifunctional nature, the promiscuity of PNKP in several DNA repair pathways 
is perhaps unsurprising. In response to single-strand breaks formed upon IR treatment, PNKP is 
required to hydrolyze the 3′-phosphate groups formed either directly or upon enzymatic treatment 
of 3′-phosphoglycolates by TDP1/ APE1 and also phosphorylate 5′-hydroxyl ends (Weinfeld et 
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al., 2011). XRCC1-deficiency sensitize cells to H2O2-induced SSBs, but this sensitization can be 
completely rescued by overexpression of a WT, but not a phosphatase-defective PNKP protein 
(Breslin et al., 2017). XRCC1 is phosphorylated by casein kinase 2 (CK2) and this phosphorylation 
promotes interaction of p-XRCC1 with the PNKP-FHA domain. Along these lines, p-XRCC1 
enhances the kinase as well as the phosphatase function of PNKP and is required for the 
recruitment of XRCC1 and PNKP to nuclear foci for SSB repair (Hanzlikova, Gittens, Krejcikova, 
Zeng, & Caldecott, 2017). PNKP depletion renders human cells sensitive to camptothecin and 
other topoisomerase 1 poisons suggesting that, similar to 3′-PG repair, PNKP functions 
downstream of TDP1 for repairing Top1-associated SSBs (Kawale & Povirk, 2018).  
Similar to SSB repair, PNKP plays a critical role in DSB repair and is a part of the elite 
cast of end processing enzymes during NHEJ. Experiments in extracts have shown that PNKP is 
critical for ligation of a 5′-hydroxyl ended linearized plasmid substrate. A549 cells depleted of 
PNKP show sensitivity to ionizing radiation. Similarly, inhibition of PNKP with a small molecule 
inhibitor confers radiosensitivity in these cells (Freschauf et al., 2009). As for SSB repair, PNKP 
interacts with XRCC4 phosphorylated by CK2 and this interaction enhances the 5′-kinase activity 
of PNKP (Weinfeld et al., 2011). Mutations in PNKP gene lead to neurological conditions 
including microcephaly with seizures (MCSZ), an autosomal recessive disorder characterized by 
a delay in development and Ataxia with Oculomotor Apraxia 4 (AOA4) characterized by ataxia 
and peripheral neuropathy (Dumitrache & McKinnon, 2017). The pathogenic mutations in MCSZ 
are associated with both the kinase and the phosphatase sub-domains of PNKP, whereas those in 
AOA4 are observed only in the kinase domains.  
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2. 4 Specific Aims 
Compared to normal cells, whole cell extracts (WCEs) from SCAN1 cells are deficient in 
processing the 3ʹ-PG termini on overhanging DSB substrates. Strangely, however, SCAN1 cells 
show neither hypersensitivity nor any deficit in the repair of DSBs induced by ionizing radiation. 
Moreover, HeLa cells with TDP1-knockdown show only marginal sensitivity to calicheamicin, 
expected to produce 3′-PG ended DSBs. This argues for the presence of other enzymes functioning 
in parallel to TDP1 for the processing of 3′-PG DSBs.  
A few candidate enzymes including apurinic/apyrimidinic endonuclease 1 (APE1) and the 
Artemis nuclease have been implicated in 3′-PG removal. However, although APE1 can process 
3′-PG on blunt or recessed DSB ends, overhanging 3′-PGs are completely refractory to removal 
by APE1. In contrast, Artemis can effectively remove 3′-PG on overhanging DSB ends by 
endonucleolytic trimming. Moreover, Artemis-deficient cells show increased sensitivity to IR as 
well as to neocarzinostatin (NCS) and bleomycin, radiomimetic agents that produce 3′-PG DSBs, 
and this sensitivity can be rescued by expressing wild-type, but not endonuclease-deficient 
(D165N) Artemis. Thus, Artemis, via its endonuclease function, is a likely candidate enzyme 
functioning in parallel to TDP1 for the repair of 3′-PG on DSB overhangs.  
In this dissertation, we proposed: 
1. To determine the biological significance of the function of TDP1 in repairing 3′-
phosphoglycolate-ended DSBs.  
2. To investigate the interplay between Artemis and TDP1 in response to radiomimetic 
3′-phosphoglycolate-terminated DSBs. 
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Polynucleotide Kinase Phosphatase is a critical enzyme for the processing of 3′-phosphate- and 5′-
hydroxyl-modifications on DNA DSBs. PNKP also participates in the base-excision repair 
pathway for repairing SSBs as well as in the PARP1-dependent alternative end joining pathway 
for DSB repair. Knockdown of PNKP conferred increased sensitivity to ionizing radiation in A549 
lung cancer cells. However, several limitations, including the heterogeneity of damage and a high 
ratio of SSBs to DSBs induced by IR, along with the persistence of residual PNKP upon its 
knockdown, complicate the interpretation of these results. To further clarify the role of PNKP, we 
proposed: 
3. To investigate the importance and biological significance of PNKP specifically in the 
repair of NCS-induced 3′-phophate-terminated DSBs.  
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3. MATERIALS AND METHODS 
 
 
 
3.1 Cell lines and reagents  
HCT116 TDP1-/- cells, constructed in the laboratory of Dr. Yves Pommier, NIH, have been 
described (Abo et al., 2017). HCT116 Artemis-/- cells were obtained from the lab of Dr. Eric 
Hendrickson, University of Minnesota. Human Embryonic Kidney (HEK) 293 cells were obtained 
from American Type Culture Collection (ATCC). HCT116, HEK293 and HEK293T cells were 
maintained in Roswell Park Memorial Institute (RPMI) 1640 medium (GIBCO) supplemented 
with 10% fetal bovine serum (Atlanta Biologicals) and antibiotics (GIBCO) at 37°C in 5% CO2 
atmosphere. 48BR WT and CJ179 Artemis deficient fibroblasts were maintained in Minimal 
Essential Medium Alpha (MEM-α) with 10% Serum (HyClone Fetal Clone II Bovine Serum), 1X 
Glutamax and antibiotics. NU-7441 (aka KU-57788), KU-60019, AZD-2287 and ABT-888 were 
obtained from Selleckchem. Neocarzinostatin (NCS) was from Sigma or Nippon-Kayaku and 
Calicheamicin (CAL) was a gift of Wyeth Pharmaceuticals (now Pfizer). 
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3.1.1 HCT116 cells.  
Artemis-/-•TDP1-/- : TDP1 was knocked out in HCT116 Artemis-/- cells using CRISPR 
editing technique as described (Abo et al., 2017).  Briefly, Artemis-/- cells were transfected 
CRISPR editing reagents along with a vector harboring a cloned sequence targeting TDP1 exon 5 
(GTTTAACTACTGCTTTGACGTGG) and a puromycin resistance gene flanked by homology 
arms upstream and downstream of the target site.  Transfected cells were selected in 0.8 µg/mL 
puromycin for 4 days.  Single cell clones were subsequently screened for TDP1 activity to obtain 
clones without any detectable TDP1 activity. 
shTDP1 and Artemis-/-•shTDP1 : For the expression of a TDP1 shRNA, the pLSLP 
lentiviral vector, a distant relative of the pLV vector containing an RNA polymerase III-driven H1 
RNA promoter controlling the expression of a small hairpin RNA (shRNA) transcript and 
harboring the puromycin N-acetyl transferase (pac) gene conferring resistance to puromycin was 
used (Budanov, Sablina, Feinstein, Koonin, & Chumakov, 2004). Phosphorylated oligonucleotides 
with sequences 5′-
GATCCGGTGATAAGCGAGAGGCTAACTTCGTGTCATTAGCCTCTCGCTTATCACTTTT
TG-3′ and 3′-
GCCAGTATTCGCTCTCCGATTGAAGGACAGTAATCGGAGAGCGAATAGTGAAAAAC
TTAA-5′ were annealed at a 1:1 ratio in annealing buffer (10 mM Tris, pH 7.5, 50 mM NaCl, 1 
mM EDTA) by heating the mixture at 95°C for 5 min followed by cooling of the mixture at a rate 
of 1°C/ min and stored at 4°C.  The lentiviral pLSLPw backbone construct was restriction enzyme 
digested using BamHI and EcoRI, dephosphorylated and gel purified.  The annealed oligomers 
were ligated in the digested lentiviral construct.  This vector expresses a hairpin that targets the 
sequence GUGAUAAGCGAGAGGCUA (bases 20300-20319 in exon 6 of the TDP1 gene, 
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GenBank #NG009164).  shTDP1 lentiviral constructs were transfected into HEK293T cells along 
with packaging plasmid psPAX2 and envelope plasmid pMD2.G using calcium chloride.  
Supernatant containing packaged lentiviral particles was collected, centrifuged at 4000 RPM at 
4°C.  The viral supernatant was then collected and filtered through a 0.25 µm filter, aliquoted in 1 
mL vials and flash frozen and stored at -80°C. HCT116 WT and HCT116 Art-/- cells were seeded 
at 75% confluency in 6-well plates and incubated for 24 hr. The medium was aspirated, cells 
washed with PBS, incubated with 1 mL of the lentiviral stock in the presence of 4 µg/mL polybrene 
overnight on a rocker at 37°C in 5% CO2. The viral supernatant was removed and cells were fed 
with fresh medium containing 0.8 µg/mL puromycin and selected for 4 days. Cells from each 
genotype were expanded under selection and cryogenic stocks were stored. Genomic DNA was 
extracted from a fraction of selected cells using QIAGEN DNeasy Blood and Tissue kit and DNA 
concentration was measured. 100 ng genomic DNA was used as a template in a 50 µL PCR 
reaction for the amplification of the puromycin resistance gene using forward primer: 5ʹ-
CGAGTACAAGCCCACGGT-3ʹ and reverse primer: 5ʹ- AGACCCTTGCCCTGGTG-3ʹ 
(synthesised by IDT) with initial denaturation at 94°C for 6 min followed by cycles of denaturation 
at 94°C for 10 sec, annealing at 58°C for 20 sec and extension at 72°C for 30 sec for 35 cycles, 
followed by a final extension step at 72°C for 7 min and analyzed on a 1% Agarose gel. Single 
cell clones were obtained and screened for maximum knockdown efficiency by TDP1 activity 
assay. 
3.1.2 HEK293 and HEK293T cells. 
TDP1-/- : HEK293 or HEK293T cells were triply transfected with hCAS9, pMaxGFP and 
a pUC19 vector expressing a gRNA targeting bp 24880-24899 in exon 7 of the TDP1 genomic 
sequence (GCAAAGTTGGATATTGCGTT) from a U6 promoter. Cells were grown on a 10 cm 
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dish to 70% confluence and then medium was replaced with 1.5 mL OptiMem (GIBCO).  A DNA 
mixture consisting of 12 µg hCAS9 (Mali et al., 2013), 2.4 µg pMaxGFP and 9.6 µg targeting 
vector was prepared in 50 µL OptiMem, combined with a transfectant solution consisting of 60 
µL Lipofectamine 2000 (ThermoFisher) and 50 µL OptiMem, incubated for 40 min at 22°C and 
then added to the medium in the dish.  Cells were bathed in the tranfection mixture for 4 hr at 37°C 
on a rocker.  The mixture was then replaced with 10 mL complete medium and the cells incubated 
for 16 hr.  Cells were harvested and single GFP+ cells were sorted into individual wells and 
expanded. DNA was isolated as above and clones with deletions/insertions at the target site in both 
alleles were identified by amplifying a 141-bp fragment encompassing the target using one Cy5-
labeled (Cy5-AAATGACAATGCTTGAGGG) and one unlabeled primer 
(CCAGTAGATATGGATATTAGTGAG), and analyzing the products on a denaturing 
sequencing gel, with detection on a Typhoon imager.  Extracts were prepared and screened for 
phosphodiesterase activity and a clone with no detectable activity (<0.1% of parental) was 
selected. 
shArtemis and shArtemis.TDP1-/- : shArtemis vector in the w16-1 backbone (pLenti X2 
Puro DEST) was obtained from the lab of Dr. Steven Yannone (Campeau et al., 2009). The 
sequence used to express double-stranded oligonucleotides encoding Artemis shRNA were: 5′- 
GATCCCCTGAAGAGAGCTAGAACAGGTGTGCTGTCCCTGTTCTAGCTCTCTTCAGTT
TTTGGAAA-3′. This vector expresses a hairpin that targets the sequence 
CTGAAGAGAGCTAGAACAG (bases 34662-34680) in exon 13 of the Artemis (DCLRE1C) 
gene, GenBank #NG_007276.1. Lentiviral stocks were generated as mentioned above. HEK293 
WT and TDP1-/- cells were seeded in 6-well plates and infected with the 1 mL of the lentiviral 
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stock. Cells were cultured in 1 µg/mL Puromycin for 5 days. Selected cells were further expanded 
to 10 cm flasks and genotyped by PCR amplification of the pac gene as mentioned above.  
3.1.3 48BR WT and CJ179 Artemis deficient fibroblasts 
TDP1 was knocked-down in 48BR normal and CJ179 Artemis-deficient fibroblasts in a 
way similar to described before for HCT116 cells. However, since these cells were already 
resistant to puromycin, the lentiviral vector was modified by inserting a Turbo-GFP gene fragment 
from the pGIPZ vector and cells were selected based on their GFP expression. pGIPZ vector was 
digested using XbaI and XhoI enzymes that releases a 2684bp fragment with the Turbo GFP and 
puromycin resistance gene under the control of a CMV promoter. pLSLPw was sequentially 
digested by XbaI and SalI to remove the puro resistance gene. Sticky ends created by digestion 
using SalI are compatible with XhoI. The vector and the insert were gel-purified and 50 ng of total 
DNA mixture was ligated overnight at 16°C in the presence using T4 DNA Ligase. Competent 
cells were then transformed with this ligated vector and allowed to form colonies overnight. 
Plasmids isolated from these colonies were ~9 kb in size. The presence of insert was confirmed by 
digesting the vector with an insert specific enzyme.  
In addition, TDP1 was also knocked out in these fibroblasts in a similar manner as 
mentioned above for HEK293 cells. Cells were bathed in the transfection mixture for 24 hours 
followed by single cell sorting using FACS. Single-cell clones were screened for absence of TDP1 
activity by TDP1 activity assay.   
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Figure 3-1: Lentiviral transfer vector pLSLPw harboring the shRNA against TDP1 
The shTDP1 construct was cloned into the BamHI and EcoRI sites seen at the bottom. The vector 
carries a puromycin N-acetyl transferase (pac) gene seen here as puro on the right in between 
XbaI and SalI sites which confers resistance to the antibiotic puromycin.  
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3.2 Dilution cloning for selection of clones. 
From the puromycin-selected cells, 5 cells were seeded in 15mL complete medium in 15 
cm dishes and the cells were made to form colonies over a period of 14 days. Following colony 
formation, the medium was removed and the colonies were washed with 5mL of PBS. A sterile 
cloning cylinder was placed on top of the colonies and 70μL trypsin was added in each ring to 
dissociate the cells. The trypsinized cells were sub-cultured into individual 10 cm dishes to obtain 
individual clones. 
3.3 Growth curve assay 
Cells (1 X105) were seeded in 6-well plates in duplicates in 3 mL complete medium. At 
the appropriate time points, cells were washed with 1X PBS, trypsinized and counted using a 
hemocytometer.  
3.4 TDP1 activity assay  
Cells (2 X 106) from each derivative cell line were collected using trypsinization and 
centrifuged at 1200 RPM for 5 min at room temperature (RT).  The cell pellet was washed once in 
1X PBS and treated with lysis buffer (10 mM HEPES at pH 7.8, 60 mM KCl, 1 mM EDTA, 0.5% 
NP-40) in the presence of 2 mM serine protease inhibitor phenylmethanesulfonyl fluoride (PMSF), 
1 mM NaVO4, 1 µg/mL leupeptin, 1 µg/mL aprotinin and 1 µg/mL pepstatin, vortexed until the 
pellet was disrupted, incubated on ice for 10 min and centrifuged at 13000 RPM for 5 min at 4°C.  
The supernatant ("cell extract") was collected and serially diluted in dilution buffer (50 mM Tris 
at pH 8.0, 5 nM DTT, 100 mM NaCl, 5 mM EDTA, 10% glycerol, 500 µg/mL BSA).  Serial 
dilutions of 1 µL of the extract was incubated with 100 attomoles of an 18-base 5′-Cy5 labelled 
3′-phosphotyrosyl oligonucleotide with sequence TCCGTTGAAGCCTGCTTT (18Y) (Midland 
Certified Reagents Midland, TX) in 1X reaction buffer (60 mM KOAc, 10 mM MgOAc, 50 mM 
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triethanolamine-HAc pH 7.5, 2 mM ATP, 1 mM DTT) in total 5 µL reaction volume and incubated 
at 37°C for 1 hr, denatured at 95°C for 5 min and separated on 20% denaturing polyacrylamide 
sequencing gels by electrophoresis for around 4 hr at 42 V/cm. Gels were then imaged on a 
Typhoon 9410 Variable Mode Imager (GE Healthcare) in Fluorescence Acquisition mode with a 
Cy5 Emission filter using a Red (633 nM) laser at PMT of 800 V and analyzed on ImageQuant 
5.1 software. 
3.5 Sequencing polyacrylamide gel electrophoresis 
Denaturing polyacrylamide gels with acrylamide: bisacrylamide ratio of 20:1 and Urea at 
a final concentration of 8M were used for separation of the oligonucleotide substrate with and 
without the Tyrosyl attached to its 3′-end. The gel dimensions were 33cm X 38cm X 0.1cm. Urea 
was dissolved into the mixture before adding 0.075% ammonium persulfate and 0.0625% TEMED 
(N, N, N’, N’-tetramethylethylene diamine). The gel was allowed to set for around 1 hour, 
following which the samples were loaded into the wells of the gel and electrophoresed at constant 
power of 60 W for around 4 hours in 1X TBE buffer (10X stock solution: 108 g of Tris base, 55 g 
of boric acid, 9.3 g of disodium EDTA in 1L Distilled water). The gel was wrapped in saran wrap 
following electrophoresis and scanned on a Typhoon 9410 Variable Mode Imager in Fluorescence 
Acquisition mode with 670BP 30 Cy5 Emission filter using a Red (633) laser at PMT of 800 V. 
3.6 Cytosol-Nuclear Fractionation 
For detection of TDP1, two million cells were fractionated using a nuclear/cytosol 
fractionation kit (BioVision #K266-25). Briefly, cells were collected by trypsinization and 
centrifuged at 600 X g for 5 min at 4°C. Cell pellets were mixed with a proprietary cytosol 
extraction buffer (CEB-A) mix containing 1mM DTT and 2X protease inhibitor cocktail. Cells 
were vortexed and incubated on ice for 10 min followed by addition of 11 µL cytosol extraction 
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buffer B (CEB-B) and incubating on ice for 1 min. Cells were centrifuged at 16000 X g and the 
supernatant was collected as the cytosolic fraction. The pellet was washed once with PBS to 
remove any contaminating cytosolic material. 100 µL of nuclear extraction buffer was added and 
the samples were vortexed for 15 sec every 10 min at 4°C. The samples were then centrifuged at 
16,000 X g for 10 min at 4°C and the supernatant was collected as the nuclear fraction. Protein 
concentration estimation was performed using a BCA assay (Pierce). 
3.7 Western blot analyses 
Laemmli buffer (2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 0.004% bromphenol 
blue, 0.125 M Tris–HCl pH 6.8) was added to the cytosolic and nuclear lysates and heated for 10 
min at 95°C. 25 µg of the nuclear and 50 µg of the cytoplasmic lysates were separated on a 10% 
polyacrylamide gel at 120V for around 2 hr. Proteins were transferred onto nitrocellulose 
membrane in 1X transfer buffer (10X - 500 mM Tris, 400mM glycine, 3.7 g SDS ) containing 20% 
methanol at a constant current of 350 mA for 2 hr. Membranes were blocked using 1% casein in 
PBS for 1 hr and then probed with either a mouse polyclonal anti-TDP1 primary antibody 
(Abnova) at a 1:1000 dilution or rabbit anti-Lamin (nuclear fractionation control) primary antibody 
at 1:3500 for 16 hr at 4°C. Membrane was washed thrice with 1X TBST for 10 min each and 
incubated in peroxidase-conjugated secondary goat anti-mouse at 1:2500 or goat anti-rabbit at 
1:5000 for 1 hr at 22°C.  Membrane was then washed thrice with 1X TBST for 10 min each and 
developed with ECL Super Signaling substrate. Lamin was used as a nuclear control.   
3.8 Clonogenic survival assays 
Cells were seeded at densities ranging from 300 to 10,000 in 6 cm dishes and incubated for 
12 hr to allow attachment.  Cells were then treated either with NCS (stock concentration 37 µM 
diluted to 2 µM in 20 mM sodium citrate buffer, pH 4.0) at concentrations ranging from 0.25 nM 
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to 2 nM for 6 hr or they were treated with CAL (stock concentration 20 µM diluted to 1 µM in 
50% ethanol, further diluted in PBS to obtain a final working concentration of 1.2 nM) at 
concentrations ranging from 0.3 pM to 2.4 pM for 24 hr.  Following treatment, cells were incubated 
in fresh medium for 9 to 12 days to form colonies. Colonies were fixed with 100% methanol for 
10 min (for HEK293 and HEK293T cells, colonies were fixed with formaldehyde solution, Sigma 
- #25249), stained with 0.5% crystal violet in 20% methanol for 10 min, washed under tap water, 
air dried and counted manually. Plating efficiency (PE) was calculated as the number of colonies 
formed/number of cells seeded *100 for each dose.  Surviving fraction (SF) was calculated as PE 
of treated/PE of control *100.  Dose enhancement factor (DEF) was calculated as IC90 of control/ 
IC90 of the mutant cell line.  For experiments using IR, cells were irradiated using a MDS Nordion 
Gammacell 40 research irradiator (ON, Canada), with a 137Cs source.  For experiments with KU-
60019, NU-7441, AZD-2287 and ABT-888, the respective inhibitor was added 1 hr prior to NCS 
treatment and left in the medium during and 24 hr after NCS treatment.  
3.9 Mitotic shake-off for G1-phase synchronization 
Cells were synchronized in the G1-phase by mitotic shake-off. Briefly, cells were seeded 
in 15 cm dishes and allowed to reach around 60-70% confluency. The dishes were kept for 1 min 
on the thermomixer set at 1000 RPM and agitated. The medium from the dish (with suspended 
mitotic cells) was collected and kept on ice. This procedure was repeated twice. The medium was 
centrifuged, the cell pellet resuspended in 1 mL media and counted. Cells were then seeded in 
individual wells of 6 well plates, harvested after 1-6 hr and then processed for cell cycle analysis. 
For survival assays, cells were counted and directly seeded in 6cm dishes and then treated after 2 
– 6hr with NCS as described above.   
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3.10 Immunofluorescence 
Twenty-five thousand cells were seeded in 4-well chamber slides (Nunc Lab Tek) and 
incubated overnight. Cells were then serum starved by incubating in 0.5% FBS/RPMI for 72 hr. 
Cells were then treated with 4 nM NCS for 1 hr and fixed at different time points using ice-cold 
4% paraformaldehyde (PFA) in 1X PBS for 10 min. Cells were permeabilized in 0.5% Triton X-
100/PBS for 10 min and blocked in 1X PBS 1% Casein blocker (Bio-Rad, 1610783) for 1 hr at 
22°C. Primary antibodies (mouse monoclonal anti 53BP1 at 1:1000 (BD Pharmingen) and mouse 
anti-TDP1 (Abnova) at 1:100 were added and incubated overnight at 4°C. Slides were washed 4 
times with PBS for 15 min each and incubated with secondary goat anti-mouse CFL594 antibody 
at 1:1000 (sc-362277) for 2 hr at 22°C. Slides were washed 4 times with PBS for 15 min each and 
post-fixed using ice-cold 4% PFA for 10 min. Nuclei were counterstained with Vectashield 
mounting medium containing 1.5 µg/mL 4ʹ -6-diamidino-2-phenylindole (DAPI) (Vector 
Laboratories, H-1200). Confocal images were obtained with the Zeiss LSM700 Confocal Laser 
Scanning Microscope equipped with a 63X, 1.4 NA oil immersion objective, located in the 
Virginia Commonwealth University Microscopy Core Facility using a 405 nm laser (DAPI) and a 
555 nm laser (CFL594). 
3.11 Cell cycle analysis by flow cytometry 
All the four cell lines were seeded at a density of 5 × 105 cells/ dish in 10 cm dishes and 
cultured in complete medium. After 24 hours, the medium was removed and cells were washed 
thrice with 1X PBS and were synchronised by serum starving them in medium containing 0.5% 
FBS for 96 hours. Cells were then treated with 4 nM NCS for 1 hr following which, the medium 
was changed. Cells were washed with PBS and released in serum and harvested after 12 hr and 18 
hr. At the prescribed time points, the medium was removed, cells were washed with PBS twice 
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and trypsinized. 1.5 X 106 cells were then counted using a hemocytometer, centrifuged at 800 RPM 
for 5 min and fixed in ice-cold 70% ethanol for minimum 1 hr. Ethanol-treated cells are more 
buoyant and thus were centrifuged at 2000 RPM for 5 min. The pellets were resuspended in 1 mL 
Propidium Iodide (PI) solution (3.8 mM Sodium Citrate, 0.05 mg/mL PI, 0.1% Triton X-100) in 
the presence of 10 µg/mL RNase A (Sigma) and stored in dark for 30 min in 5 mL Polystyrene 
Round-Bottom Tube with Cell-Strainer Cap (Fisher Scientific). Cell Cycle Analysis was 
performed using a Becton Dickinson (San Jose, CA) FACS Canto II flow cytometer. The argon 
ion laser set at 488 nm was used as an excitation source. Cells having DNA content 2N were 
designated as being in the G1 phase of the cell cycle, those having 4N were designated as being in 
the G2 phase while the cells showing intermediate DNA content between 2N and 4N were 
designated as S-phase cells. Minimum ten thousand events were acquired for each sample and the 
data obtained was analysed using the Modfit LT software.  
3.12 Centromere-fluorescence in situ hybridization 
One million cells were seeded in 6-cm dishes and incubated overnight. Cells were treated 
with 1 mM caffeine to abrogate the G2/M block 10 min before treating with 2 nM NCS for 6 hr. 4 
hours into NCS treatment, cells were treated with 1 μg/mL colchicine for 2 hr. After 6 hr NCS 
treatment, cells were collected by trypsinization, washed with PBS and swollen in 75 mM KCl for 
10 min at 37°C, then centrifuged and fixed with ice-cold Carnoy’s fixative (3:1 methanol:glacial 
acetic acid) for 10 min. Samples were centrifuged and washed twice with methanol/acetic acid. 
Cells were dropped onto ethanol-cleaned, ice-cold slides and dried overnight. Slides were 
dehydrated by immersing for 2 min each in 70%, 90% and 100% ethanol followed by baking at 
65°C for 10 min, washing in acetone for 10 min and air drying. Slides were treated with 100 μg/mL 
RNase A in 2X SSC under a parafilm coverslip for 30 min at 37°C then washed for 5 min in 
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2XSSC and for 10 min in PBS, dehydrated in an ethanol series and allowed to dry. Chromosomes 
were denatured by immersing in 70% formamide / 2XSSC (pH =7) for 2 min at 75°C and then in 
ice-cold 70% ethanol for 2 min. Slides were again dehydrated in an ethanol series and air-dried. 
25 µL of 200 nM Cy3-labeled PNA CENP-B probe (PNA Bio – F3002) in hybridization buffer 
(20 mM Tris, pH 7.4, 60% formamide, 0.1 µg/mL salmon sperm DNA) was added, covered with 
a 24 mm X 50 mm coverslip and allowed to hybridize for 2 hr at 37°C in dark. Slides were then 
washed in 2X SSC for 5 min at 37°C, three changes of 0.5X SSC / 0.3% NP-40 for 10 min at 55°C, 
two changes of 2X SSC / 0.1% NP-40 for 5 min at 22°C, and finally in 2X SSC for 5 min at 22°C. 
The washed slides were dried and counterstained with Vectashield mounting medium containing 
DAPI (Vector Laboratories) under a coverslip and was sealed with nailpolish. Metaphases were 
then imaged using a Zeiss LSM700 Confocal Microscope as described. For experiments using 
NU-7441, the inhibitor was added 1 hr prior to NCS treatment. All washes were performed in 50-
mL glass Coplin jars. 
3.13 Transformation 
Transformation reactions were performed using the NEB Turbo or Alpha-Gold Select 
competent cells. 25µL aliquots of cells were thawed on ice and incubated with 50 ng (2 µL) of the 
plasmids on ice for 30 min, then subjected to a heat shock for 30 sec at 42°C followed by 2 min 
incubation on ice. Pre-warmed SOC medium (1 mL) was added and the reactions were incubated 
at 37°C with shaking at 1000 RPM for 1 hour. Culture was spread on LB Carbenicillin plates at 3 
dilutions and incubated overnight at 37°C.  
3.13 Statistics 
Graphical analysis was performed using SigmaPlot 13 statistical software. Statistical 
significance values were obtained by performing a Two-way Anova followed by Holm-Sidak post-
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hoc test for all clonogenic survival assays whereas unpaired two-tailed students t-test was used for 
53BP1 repair kinetics analysis and FISH experiments.   
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4. RESULTS 
 
 
 
4.1 Generation of TDP1-mutant (shTDP1 and TDP1-/-) cell lines 
It has been previously shown that TDP1 is critical for the repair of overhanging 3′-
phosphoglycolates on model DSB substrates in whole cell extracts (Hawkins et al., 2009). 
However, experiments performed to understand the role of TDP1 in DSB repair in cells have 
shown otherwise (El-Khamisy et al., 2005; Hawkins et al., 2009; Zhou et al., 2009). In order to 
clearly demonstrate the role of TDP1 in DSB repair, TDP1 was knocked-down in WT HCT116 
human colorectal adenocarcinoma cell line using a lentiviral vector carrying a small hairpin RNA 
for TDP1 (Budanov et al., 2004; Chumakov, Kravchenko, Prassolov, Frolova, & Chumakov, 2010) 
(Fig 3-1). Cells were selected in medium containing 0.8 µg/mL puromycin for four days. Single 
cell clones were obtained by dilution cloning using cloning towers. Stable single cell clones were 
then scaled up and cultured in 6-well plates. Stable single-cell clones were screened for maximum 
knockdown efficiency using a biochemical gel-based TDP1 activity assay, capable of detecting as 
little as 0.1% TDP1 activity. Due to the high specificity of TDP1 towards 3′-phosphotyrosyl 
oligonucleotides, TDP1 catalytic activity was measured in cell extracts by the extent of the 
conversion of a 5′-Cy5-labelled 18-base oligonucleotide substrate bearing a 
 60 
 
3′-phosphotyrosine (18pY) to a 3′-phosphate (18p) product migrating with an increased 
electrophoretic mobility in a polyacrylamide gel (Gao et al., 2014). Clone #18 (shTDP1#18) 
showed maximum (94%) knockdown efficiency with 6% residual TDP1 expression (Fig. XX). 
Similarly, HCT116 TDP1-/- cells, screened for TDP1 activity, demonstrated a complete lack of 
conversion of 18Y to 18P (Fig. 4-1).  
In addition to HCT116 cells, TDP1 was also knocked out in HEK293 and HEK293T cells. 
Initial attempts at CRISPR/Cas9-mediated knockout of TDP1 targeting the initiation codon 
resulted in several clones with homozygous deletions that nevertheless harbored a low (1 to 2% of 
parental) level of tyrosyl-DNA phosphodiesterase activity, suggesting a possible alternatively 
spliced or translated enzyme. Therefore, the TDP1 active site in exon 7 was targeted instead. 
Clones with deletions/insertions in both alleles were identified and whole-cell extracts were 
screened for phosphodiesterase activity. One TDP1-/- clone produced extracts that completely 
failed to hydrolyze the 18pY substrate to 18p product (<0.1% of WT activity, Fig. 4-2A).  In 
addition, TDP1 was immuno-labelled and cells were analyzed for TDP1 expression by confocal 
microscopy. HEK293 WT but not TDP1-/- cells, showed robust TDP1 expression observed as red 
fluorescence in the nuclei of these cells (Fig 4-2B). Some cytoplasmic red fluorescence was 
observed in TDP1-/- cells as well although this was presumably non-specific. TDP1 expression was 
also analyzed by performing a western blotting experiment to further confirm the above results. 
The antibody against TDP1 was not sensitive and specific enough to detect TDP1 in whole cells 
extracts. Hence, cyto-nuclear fractionation was performed to enrich TDP1 in the nuclear extracts 
of these cells as done previously (Zhou et al., 2009). Western blotting performed in these fractions 
showed an absence of a band corresponding to TDP1 protein in nuclear extracts of TDP1-/- 
compared to TDP1+/+ WT cells (Fig 4-2C). 
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Figure 4-1- TDP1 expression in HCT116 cells.  
(A, B) 18-base oligonucleotide substrate with a phosphotyrosine attached to the 3′-end was 
incubated with serially-diluted whole cell extracts of HCT116 WT and shTDP1#18 in (A) and 
TDP1-/- in (B) for 1 hour and separated on a 20% polyacrylamide gel. Processed (18-P) and 
unprocessed (18-pTyr) forms of the substrate and serial dilutions of the extracts are indicated. 
Substrate incubated in reaction buffer instead of cellular extract is represented as untreated 
substrate in (B). (C and D) Percentage of TDP1 Activity remaining in whole cell extracts as 
observed in B. 
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Figure 4-2: TDP1 expression in HEK293 cells.  
(A) 18-base oligonucleotide substrate with a phosphotyrosine attached to the 3′-end was 
incubated with serially-diluted whole cell extracts of HEK293 WT and TDP1-/- cell lines for 1 
hour and separated on a 20% polyacrylamide gel. Processed (18-P) and unprocessed (18-pTyr) 
forms of the substrate and serial dilutions of the extracts are indicated. Substrate incubated in 
reaction buffer instead of cellular extract is represented as untreated substrate. (B) Loss of 
TDP1 in HEK293 TDP1-/- cells as observed from immunolabelling for TDP1 followed by 
confocal microscopy. Red fluorescence: TDP1 (1:1000, 1° anti-TDP1 Abnova, 2° anti-mouse 
CFL594, SCBT). (C) Western blot depicting loss of TDP1 protein from the nuclear extracts of 
HEK293 TDP1-/- cells. 
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4.2 TDP1 deficient cells are hypersensitive to ionizing radiation and radiomimetic agents.  
Previously, in vitro studies performed using whole cell extracts from TDP1-mutant SCAN1 
cells showed that TDP1 is critical for processing the 3′-PG termini from DSB overhangs (Hawkins 
et al., 2009; Inamdar et al., 2002; Zhou et al., 2009). To further investigate the biological 
significance of TDP1’s function, clonogenic survival assays were performed in HCT116 WT, 
TDP1-knockdown and TDP1-knockout cells using Neocarzinostatin (NCS) and Calicheamicin 
(CAL), enediyne antitumor antibiotics that produce bi-stranded lesions, a substantial portion of 
which bear 3′-PG termini. TDP1-deficient (shTDP1 and TDP1-/-) cells showed significant 
hypersensitivity to both NCS (Fig. 4-3A) and CAL (Fig. 4-3B) with a DEF of 1.6 X and 2 X 
respectively, as compared to the parental cells.  
HCT116 cells show reduced Mre11 expression (Takemura et al., 2006). Mre11 functions 
in an alternative, TDP1-independent pathway for the repair of Top I-induced breaks (Sacho & 
Maizels, 2011). Thus, to investigate whether the hypersensitivity seen in TDP1-deficient HCT116 
cells was specifically a function of TDP1 deficiency and not due to parallel TDP1-dependent and 
Mre11-dependent pathways being disrupted, TDP1 was knocked out in HEK293 and HEK293T 
cells  which express normal levels of Mre11 (Staples et al., 2016), and clonogenic survival assays 
were performed in the these cells. Importantly, TDP1-/- derivatives of both HEK293 and HEK293T 
cells showed significant hypersensitivity to NCS compared to parental TDP1+/+ cells (Fig. 4-
4A,B). TDP1-deficient cells were complemented with a human recombinant TDP1 protein. 
Surprisingly, the recombinant TDP1 only partially rescued the sensitivity of TDP1-/- cells to NCS 
but almost fully to radiation (Fig 4-4C). In summary, these experiments demonstrated that TDP1 
is not an essential gene, but that its absence results in significant cellular sensitivities consistent 
with observations from other laboratories (Abo et al., 2017; J. Li et al., 2017).  
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Figure 4-3: Loss of TDP1 enhances the cytotoxicity of radiomimetic agents in HCT116 cells.  
Clonogenic survival assays were performed on HCT116 cells treated with NCS (A) and 
Calicheamicin (B). Error bars represent SEM over at least three independent experiments for all 
except TDP1-/- HCT116 where n=2. Data were analyzed using Two-way Anova. . * - p<0.05, ** 
- p<0.005, *** - p<0.001 
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Figure 4-4: Loss of TDP1 enhances the cytotoxicity of radiomimetic agents in HEK293 and 
HEK293T cells.  
(A, B, C) Clonogenic survival assays were performed on HEK293 (A, B) and HEK293T cells (C) 
treated with NCS or radiation. Error bars represent SEM over at least three independent 
experiments for all except TDP1-/- HCT116 where n=2. 
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4.3 Generation of TDP1 and Artemis double knockouts 
The Artemis nuclease functions in the NHEJ pathway of DSB repair and is biochemically 
competent in resolving 3′-PG termini by end trimming (H. Chang H.Y. & Lieber, 2016; Lieber, 
2010; Povirk et al., 2007). Thus, to investigate whether Artemis and TDP1 are alternative end 
processing enzymes functioning in the same pathway for the resolution of 3′-PG termini, HCT116 
Artemis-knockout cells were obtained from the lab of Dr. Eric A. Hendrickson. To augment these 
cells, TDP1 was subsequently knocked out in Artemis-/- cells to generate Artemis-/-•TDP1-/- double 
knockout (DKO) mutants. In addition, TDP1 was also knocked down in Artemis-/- cells to create 
a double-mutant Artemis-/-•shTDP1 cell line. Stable integration of the lentiviral vector in pooled 
cells was analyzed by extracting genomic DNA and PCR amplification of the pac gene (Fig. 4-
5A). Moreover, genotypic confirmation of Artemis-/- single as well double mutants was performed 
by PCR amplification of the Exon 2 of Artemis gene (Fig. 4-7A). Upon genotypic confirmation of 
the selected pool, single cell clones were isolated and a TDP1 activity assay performed on these 
clones identified clone #2 as displaying maximum knockdown efficiency with a loss of around 
92% activity (Fig. 4-5B, C & D). Consistent with a role for TDP1 in the repair of Top 1-mediated 
DNA lesions (Kawale & Povirk, 2018; Pommier et al., 2014), Artemis-/-•shTDP1#2 double mutant 
cells were more sensitive to the Top 1 poison, camptothecin (CPT) than Artemis-/- cells (Fig. 4-
5E). All the mutant cell lines showed slower growth rates compared to WT cells with the double 
mutants showing the longest delay (Fig. 4.6)   
Similarly, Artemis was also knocked-down in HEK293 WT and HEK293 TDP1-/- cells 
using a lentivirus carrying an shRNA against Artemis. Cells were selected in 1 µg/mL puromycin 
and single cell clones were isolated. RT-PCR was performed to screen clones showing the highest 
knockdown efficiency.  
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Moreover, to compare the cellular response in normal and cancer cell lines, TDP1 was also 
knocked down in 48BR-hTert WT and CJ179-hTert Artemis-deficient fibroblasts. Since these cells 
were already resistant to puromycin (hTert vector had Puromycin resistance gene, used to select 
immortalized cells carrying hTert), the pLSLP-shTDP1 lentiviral vector was modified by replacing 
the endogenous puromycin resistance gene by a fragment carrying a Turbo-GFP and a puromycin 
resistance gene under the control of a CMV promoter. An internal ribosomal entry site (IRES) 
sequence after the GFP gene allows the puromycin resistance gene to be expressed from a 
polycistronic mRNA carrying the GFP and pac gene CDS. Lentiviral stocks were made and 48BR 
and CJ179 fibroblasts were infected with the lentiviral stocks and selected based on high GFP 
expression by FACS.  
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Figure 4-5: Characterization of Artemis-/-•shTDP1 cell line  
(A) Genotypic confirmation of the lentiviral integration in the genomic DNA of cells infected 
with the shTDP1 lentivirus as observed from the amplification of the puromycin resistance gene. 
WT pTripz and pTripz are positive controls whereas uninfected Artemis-/- was negative control. 
(B) TDP1 Activity assay (as in Fig 2, 3) in HCT116 Artemis-/- and 2 clones with an additional 
TDP1 knockdown. Values below the lane indicate the dilution factors of the extract. Lanes where 
values are not mentioned represent undiluted extracts. (C and D) Percentage of TDP1 Activity 
remaining in whole cell extracts as observed in B. (E) Clonogenic survival assays performed 
upon treatment with Top 1 poison, camptothecin for 24 hours. Error bars represent SEM, n = 2. 
** - p<0.005, *** - p<0.001. 
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Figure 4-6: Growth curve 
Cells (1 × 105) were seeded in 6-well plates in 3mL complete medium and were counted using a 
hemocytometer on days 1, 3 and 5. The above graph shows the number of cells in million versus 
number of days. n=2. 
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Figure 4-7: Characterization of HCT116 Artemis-/-.TDP1-/- mutant cells 
(A) Artemis Exon 2 was amplified by PCR and the samples run on a 1% agarose gel. TDP1-/- is 
negative control. Artemis-/- is positive control. (B and C) TDP1 activity assay in various clones 
of Artemis-/-.TDP1-/-. Values below the lane indicate the dilution factors of the extract. Lanes 
where values are not mentioned represent undiluted extracts. (D) Quantification of processing of 
the tyrosyl moiety from the substrate as a function of the concentration of the extract.  
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4.4 TDP1 and Artemis are epistatic for the repair of 3′-PG DSBs via NHEJ 
In order to determine whether TDP1 and Artemis are alternative end-processing enzymes 
in the repair of 3′-PGs, clonogenic survival assays were performed using NCS, CAL and IR in the 
WT and the mutant cells. Artemis-/- cells were, as expected, hypersensitive to NCS and CAL with 
a DEF of 1.5 (NCS) and 2 (CAL). Surprisingly, however, an additional TDP1 deficiency in 
Artemis-/- cells (Artemis-/-.TDP1-/- or Artemis-/-•shTDP1#2 #2) did not enhance the 
hypersensitivity to NCS and to CAL, indicating that TDP1 and Artemis are epistatic and function 
in the same pathway for the repair of NCS/CAL-induced 3′-PG DSBs (Fig 4-8).  In all cases, 
shTDP1 knockdown was as effective as TDP1 knockout in conferring NCS sensitivity, indicating 
that knockdown was sufficient to fully express the deficiency in repair of NCS-induced damage.  
In contrast, the double mutants were more sensitive to IR compared to the single mutants (Fig. 4-
8) suggesting that TDP1 and Artemis function in parallel for the repair of IR-induced DSBs. 
NHEJ is the pathway of choice for DSB repair in G1 phase (S. E. Lee, Mitchell, Cheng, & 
Hendrickson, 1997; Lobrich & Jeggo, 2017; Valerie & Povirk, 2003). Thus, if DSBs are induced 
in cells in G1 phase, cell cycle checkpoints will be activated and further progression of the cell 
cycle will be halted until the damage is repaired by NHEJ. Thus, to investigate whether TDP1 and 
Artemis are also epistatic in the G1 phase for the repair of 3′-PG DSBs via NHEJ, clonogenic 
survival assays were performed using NCS on cells synchronized in G1 by mitotic shake-off 
(Schorl & Sedivy, 2007). Cells undergoing mitosis round-up and are loosely attached to the tissue 
culture dish. Agitation of the dish allows these M-phase cells to detach and float in the supernatant. 
The supernatant can then be centrifuged and the M-phase cells collected, seeded in a new dish and 
harvested at different time points to obtain a synchronized population of cells. This experiment 
was performed in HCT116 cells by harvesting up to 6 hours after shake-off and analyzing their 
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cell cycle profile by FACS. Approximately 80% cells were synchronized in G1 phase as 
determined by cell cycle analysis using PI staining (Fig. 4-9). Similar to the observation in 
exponentially growing cells, the hypersensitivity to NCS observed in G1-synchronized Artemis-/-
•shTDP1#2 double-mutants was similar to the Artemis-/- and shTDP1#18 single-mutants (Fig. 4-
10), suggesting that Artemis and TDP1 are epistatic for the repair of NCS-induced 3′-PG DSBs in 
G1 phase. 
Since TDP1 and Artemis function in the same pathway for the repair of NCS-induced 
DSBs in the G1-phase, the next logical line of investigation was whether they are epistatic with 
NHEJ factors. DNA-PKcs is critical for the repair of DSBs via NHEJ (Davis & Chen, 2013). DNA-
PKcs interacts with Ku70/80 heterodimer to form the DNA-PK core complex and recruits several 
DNA repair factors to the DSB ends by phosphorylation (Davis, Chen, & Chen, 2014). 
Interestingly, DNA-PK can phosphorylate itself and this autophosphorylation activity is important 
for movement of the DNA-PK complex inward from the DSB ends and thereby regulate access to 
DNA end-processing enzymes (Uematsu et al., 2007). An inhibitor of kinase activity of DNA-PK 
can block this autophosphorylation and thereby stall NHEJ causing persistent DSBs (Dong et al., 
2017; Dong et al., 2018). Therefore, in order to investigate whether Artemis and TDP1 repair 3′-
PG DSBs via NHEJ, clonogenic survival assays were performed using NCS in the presence of a 
DNA-PK inhibitor, NU-7441. WT cells showed an increased hypersensitivity to NCS upon DNA-
PK inhibition whereas additional depletion of TDP1 (shTDP1#18), deficiency of Artemis 
(Artemis-/-) or both combined (Art-/-•shTDP1#2) did not further enhance this sensitivity (Fig. 4-
11).  This result strongly suggests that Artemis and TDP1 are epistatic with DNA-PK and 
contribute to the repair of 3′-PG DSBs via the NHEJ pathway. 
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Figure 4-8: TDP1 and Artemis are epistatic for the repair of 3′-PG-ended DSBs 
Clonogenic survival assays were performed on isogenic HCT116 WT, TDP1-deficient, Artemis-
deficient, and TDP1/Artemis double-deficient cells treated with NCS (A), Calicheamicin (B) and 
ionizing radiation (C). Error bars represent SEM. n=2 for TDP1-/- and Art-/-.TDP1-/- cells 
whereas n=3 for WT, shTDP1, Art-/-, Art-/-shTDP1. For (A), n=5 for WT, shTDP1, Art-/-, Art-/-
shTDP1. Data were analyzed using Two-way ANOVA. ** - p<0.005, *** - p<0.001. In (C), *** 
indicates Art-/-.TDP1-/- comparison with WT, $$ indicates Art-/-.TDP1-/- comparison with Art-
/- and TDP1-/- single mutants implying that the double mutants are more sensitive than the 
single mutants and WT. 
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Figure 4-9: Cell Cycle Synchronization by Mitotic shakeoff 
Cells were fixed and processed at the indicated time points after mitotic shake-off for cell cycle 
analysis 0 hr represents samples processed immediately after shaekoff without re-seeding them. 
Representative FACS histogram plot showing the percentage of cells in each phase of the cell 
cycle. Horizontal axis depicts the DNA-content. A minimum of 10,000 events were collected for 
each sample. 
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Figure 4-10: TDP1 and Artemis are epistatic in the G1-phase for the repair of 3′-PG-ended 
DSBs 
Clonogenic survival assays were performed on G1 -synchronized cells treated with NCS. Error 
bars represent SEM for n=4. Data were analyzed using Two-way ANOVA, *** - p<0.001, ** - 
p< 0.005. 
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Figure 4-11: TDP1 and Artemis are epistatic with DNA-PK for the repair of NCS-induced 
DSBs. 
Clonogenic survival assays were performed in cells treated with NCS in the presence of 1 µM 
DNA-PK inhibitor, NU-7441. NU-7441 was added 1 hr prior to NCS treatment and left in the 
medium during and 24 hr after NCS treatment. . shTDP1, Art-/- and Artemis-/-•shTDP1#2  
curves are the same as in Fig. XX. Error bars represent SEM for n=4. Data were analyzed using 
Two-way ANOVA, *** - p<0.001, *** represents significant statistical difference between all 
DNA-PK inhibitor treated cells vs all cells without DNA-PK inhibitor treatment. 
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4.5 Absence of Artemis but not TDP1 confers a defect in DSB rejoining  
Upon DSB formation, several proteins localize to the sites of DSBs to elicit a DNA damage 
response, that helps repair the DSBs (Ashley & Kemp, 2018; Blackford & Jackson, 2017). ATM 
kinase is one of the early responders and phosphorylates the histone variant H2AX at the S139 
position, referred to as γ-H2AX (Burma, Chen, Murphy, Kurimasa, & Chen, 2001; Rogakou et al., 
1998). This post-translational modification serves as a signal for the recruitment of various 
proteins including ring finger proteins, RNF168 and RNF8 that ubiqutinate histone H2A at 
K13/K15 (Panier & Boulton, 2014). This ubiquitnation signals the recruitment of another repair 
factor, 53BP1 (p53-binding protein 1) which binds to ubiquitinated and methylated histones and 
channels DSB repair towards the NHEJ pathway by acting as a barrier to DNA end-resection 
(Escribano-Diaz et al., 2013).  
To directly assess whether the hypersensitivity shown by the mutants to NCS and CAL 
was due to a deficiency in repairing 3′-PG-ended DSBs, an initial attempt was made to quantify γ-
H2AX foci as DSB markers. However, the staining pattern of the γ-H2AX antibody was pan-
nuclear in addition to labelling chromatin foci representing DSBs making it very difficult to 
quantify these foci. Hence, 53BP1 foci (which colocalize with γ-H2AX foci and represent 
surrogate markers of unrejoined DSBs) were quantified as representative markers of DSBs in these 
cells following NCS treatment.  
This assay was performed on serum-deprived G0/G1-phase cells to specifically analyze 
DSB repair in the context of NHEJ and to avoid including spontaneous focus formation at stalled 
replication forks. As expected, all cells showed a robust but similar increase in 53BP1 foci 
immediately upon treatment with both 2 nM as well as 4 nM NCS. WT cells showed a typical 
biphasic kinetic curve with an intitial fast component repairing almost 70% or the breaks within 
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the first 4 hours followed by a slow component that repaired the next 20% breaks over 16 hours 
(Fig. 4-12, 4-16). Surprisingly, TDP1-depleted cells showed a similar phenotype to WT cells and 
did not show a DSB rejoining defect as expected from their sensitivity to NCS seen in survival 
assays indicating that TDP1-depletion does not confer a defect in DSB rejoining (Fig. 4-13, 4-16). 
Artemis-deficient cells (Artemis-/- and Artemis-/- •shTDP1) showed an increased persistence and a 
delayed disappearance of 53BP1 foci, with a significant fraction of foci persisting even at 8 and 
16 hr after NCS treatment compared to Artemis-proficient cells (Fig. 4-14, 4-15, 4-16). This result 
was consistent at both 2 nM and 4 nM concentration of NCS as shown in Fig. 4-17. Overall, these 
results demonstrate a defect in DSB rejoining only in the absence of Artemis but not TDP1.  
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Figure 4-12: Representative confocal images of 53BP1 repair foci in HCT116 WT cells. 
Immunostaining was performed to detect formation and disappearance of 53BP1 foci upto 16 hr 
after 4nM NCS treatment for 1 hr. 0 hr represents samples processed immediately upon NCS 
treatment. Red fluorescence: 53BP1 (BD Transduction Laboratories), Blue fluorescence: DAPI 
staining the DNA – nucleus (Vectashield). 
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Figure 4-13: Representative confocal images of 53BP1 repair foci in HCT116 shTDP1#18 
cells. 
Immunostaining was performed to detect formation and disappearance of 53BP1 foci upto 16 hr 
after 4nM NCS treatment for 1 hr. 0 hr represents samples processed immediately upon NCS 
treatment. Red fluorescence: 53BP1 (BD Transduction Laboratories), Blue fluorescence: DAPI 
staining the DNA – nucleus (Vectashield). 
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Figure 4-14: Representative confocal images of 53BP1 repair foci in HCT116 Artemis-/- cells. 
Immunostaining was performed to detect formation and disappearance of 53BP1 foci upto 16 hr 
after 4nM NCS treatment for 1 hr. 0 hr represents samples processed immediately upon NCS 
treatment. Red fluorescence: 53BP1 (BD Transduction Laboratories), Blue fluorescence: DAPI 
staining the DNA – nucleus (Vectashield). 
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Figure 4-15: Representative confocal images of 53BP1 repair foci in HCT116 Artemis-/-
•shTDP1#2 #2 cells. 
Immunostaining was performed to detect formation and disappearance of 53BP1 foci upto 16 hr 
after 4nM NCS treatment for 1 hr. 0 hr represents samples processed immediately upon NCS 
treatment. Red fluorescence: 53BP1 (BD Transduction Laboratories), Blue fluorescence: DAPI 
staining the DNA – nucleus (Vectashield). 
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Figure 4-16: Artemis-deficient but not TDP1-depleted cells show a DSB rejoining defect 
53BP1 foci were scored in serum-starved cells treated with 4 nM NCS for 1 hr and results 
plotted as number of 53BP1 foci per nucleus. Foci were counted using ImageJ whereas the 
counting of nuclei was done manually. Error bars represent SEM for n=3. Data were analyzed 
using unpaired two-tailed Students t-test, * - p<0.05, indicates comparison between Artemis-
proficient (HCT116 WT and shTDP1) and Artemis-deficient (Art-/- and Artemis-/-•shTDP1#2 ) 
cells. 
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Figure 4-17: Dose-dependent increase in 53BP1 foci 
53BP1 foci were scored in serum-starved cells treated with 2 nM and 4 nM NCS for 1 hr and 
results plotted as number of 53BP1 foci per nucleus. 0 nM samples represent untreated samples. 
Error bars represent SEM for n=3. Data were analyzed using unpaired two-tailed Students t-
test, * - p<0.05, indicates comparison between Artemis-proficient (HCT116 WT and shTDP1) 
and Artemis-deficient (Art-/- and Artemis-/-•shTDP1#2 ) cells. 
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4.6 Loss of TDP1 but not Artemis leads to misjoining of 3′-PG DSBs  
Why are 3′-PG-terminated DSBs cytotoxic in the absence of TDP1 despite being rejoined 
with kinetics similar to cells proficient in TDP1? An explanation to this discrepancy can be 
provided by understanding the fate of a DSB in cells and the limitation of the 53BP1 repair assay 
to detect all these fates. Theoretically, a DSB can be potentially channeled to accurate repair in the 
presence of the canonical repair factors, remain un-rejoined due to dysfunctional repair pathways 
or can be misjoined due to error-prone backup proteins in the absence of canonical factors. 
Although the 53BP1 repair kinetics assay is a standard for measuring the fraction of DSBs that 
remain unrejoined, it is limited by its inability to differentiate between DSB ends that are correctly 
rejoined, and DSB ends that are misjoined to ends of other DSBs in the cell.  
Previously, it has been reported that TDP1-mutant SCAN1 cells show increased 
chromosomal sensitivity to CAL and a significant increase in the number of CAL-induced 
dicentric chromosomes compared to normal cells implying that more DSBs were misjoined and 
repaired inaccurately in the absence of functional TDP1 (Zhou et al., 2009). Thus, the toxicity of 
3′-PG-ended DSBs in TDP1-depleted cells (shTDP1#18 and Artemis-/-•shTDP1#2) could be 
because of inaccurate and mis-joined DSBs due to repair being shunted to a more error-prone 
pathway. To test this hypothesis, centromere-fluorescence in situ hybridization (C-FISH) was 
performed using 2 nM NCS. As with CAL-treated SCAN1 cells, shTDP1#18 single and Artemis-
/-•shTDP1#2 double mutants showed a significant increase in the levels of NCS-induced dicentric 
chromosomes compared to WT and Artemis-/- cells, as measured on metaphase spreads with Cy3-
labelled centromeres (Fig. 4-18, 4-19). Furthermore, all mutants showed an increase in the number 
of acentric chromosomal fragments (Fig. 4-19), as would be expected since both unjoined 
fragments and fragments misjoined to each other would be scored as acentrics. In addition, the 
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Artemis-/-•shTDP1#2 showed a statistically higher number of total aberrations than either WT or 
either single mutant alone (Fig. 4-19).  Thus, although Artemis and TDP1 appear epistatic for 
promoting survival against these breaks, their loss results in disparate phenotypes. Absence of 
Artemis is cytotoxic as it hampers rejoining in a fraction of DSBs whereas the cytotoxicity in the 
absence of TDP1 is as a result of erroneous misjoining of DSBs. Similarly, even in HEK293 TDP1-
/- cells, there was an increase in the number of mis-joined chromosomes and overall increased 
chromosomal abnormalities as compared to HEK293 WT cells upon 2 nM NCS treatment (Fig. 4-
20, 4-21).  
In order to examine the contribution of NHEJ towards the mis-joining of DSB ends in the 
absence of TDP1, C-FISH was performed on cells treated with NCS in the presence of the DNA-
PK inhibitor, NU-7441.  Treatment with NU-7441 prevents the inward translocation of DNA-PK 
from DSB ends, thereby limiting access to the nucleases and phosphodiesterases required for the 
processing of modified ends (Davis et al., 2014).  DNA-PK inhibition had no effect on DSB mis-
joining in WT and Artemis-/- cells but led to a decrease in DSB mis-joining in TDP1-depleted 
shTDP1#18 and Artemis-/-•shTDP1#2 cells down to the level of TDP1-proficient WT and Artemis-
/- cells, as all four cell lines showed similar levels of dicentric chromosomes per metaphase (Fig. 
4-19).  Overall, the DNA-PK inhibitor data suggest that while there is a component of mis-joining 
in both WT and TDP1-deficient cells that is independent of C-NHEJ, the additional mis-joining in 
TDP1-deficient cells is C-NHEJ-dependent. 
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Figure 4-18: TDP1 depletion leads to misjoining of DSBs. 
Metaphase spreads of HCT116, shTDP1#18, Art-/- and Artemis-/-•shTDP1#2  #2 cells. Cells 
were treated with 2nM NCS for 6 hours. Centromeres were labelled with a Cy3-conjugated 
fluorescent probe (PNA Bio Inc.). Red arrows represent dicentric chromosomes, yellow arrows 
represent acentric fragments.  
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Figure 4-19: Chromosomal Aberrations in HCT116 cells upon NCS treatment 
A total of approximately 40-45 metaphases from 3 independent experiments were imaged, scored 
for the presence of dicentric chromosomes (A), acentric fragments (B) and total aberrations (C) 
and results plotted as number of aberrations (dicentrics, acentrics or overall aberrations) per 
metaphase. Total aberrations include acentrics, dicentrics, breaks, gaps, radials, unstructured 
chromosomal regions. Error bars represent SEM. n=2 for DNA-PKi samples, n=3 for others. * - 
p<0.05, *** - p<0.0005 
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Figure 4-20: TDP1 deficiency leads to increased chromosomal aberrations in HEK293 cells 
upon NCS treatment 
Cells were treated with 2nM NCS for 6 hours. Centromeres were labelled with a Cy3-conjugated 
fluorescent probe (PNA Bio Inc.). Red arrows represent dicentric chromosomes, yellow arrows 
represent acentric fragments. White arrows represent other aberrations. 
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Figure 4-21: Chromosomal Aberrations in HEK293 cells upon NCS treatment 
A total of approximately 40-45 metaphases from 3 independent experiments were imaged, scored 
for the presence of dicentric chromosomes (A), acentric fragments (B) and total aberrations (C) 
and results plotted as number of aberrations (dicentrics, acentrics or overall aberrations) per 
metaphase. Total aberrations include acentrics, dicentrics, breaks, gaps, radials, unstructured 
chromosomal regions. 
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4.7 Absence of Artemis delays G1-S progression upon DSB induction; this delay is rescued 
in an additional absence of TDP1 
An important facet of DSB repair involves activation of cell cycle checkpoints that arrest 
progression of cells through the cell cycle, providing enough time for the cells to repair the induced 
damage. This arrest is critical as it prevents the dissemination of damaged chromosomes to 
daughter cells upon mitosis. HCT116 cells used in the current study are p53-positive and show an 
efficient ATM-mediated G1-block in response to DSBs. Thus, in order to investigate whether 
TDP1 and Artemis play a role in regulating cell cycle progression from G1 to S phase in response 
to NCS-induced DSBs, cell cycle analysis was performed.  
An initial mapping experiment was performed to determine the basic cell cycle profiles of 
HCT116 WT cells and their isogenic mutant derivatives. Cells were synchronized in the G0/G1 
phase by serum starvation for 96 hours and then released in serum containing medium for up to 18 
hours. All cells showed a similar progression from G1 to S-phase. At 12 hr, Artemis-/-•shTDP1#2 
cells showed a slight delay in progression as compared to the WT and the single mutants. However, 
this difference was abolished at 18 hr (Fig. 4-22). Since a considerable fraction of cells were still 
in G1-phase 18hr after release in serum, it was hypothesized that these cells possibly reflect a 
fraction that re-enter cell cycle following mitosis. Indeed, when cells were released in serum with 
100 ng/mL nocodazole, the fraction of cells in G1-phase decreased significantly (Fig. 4-23). 
Nocodazole is a microtubule inhibitor that arrests cells in the M-phase and prevents them from 
dividing and subsequently re-entering into G1-phase.  
Next, cells were treated with 2 nM NCS for 6 hours after serum starvation and then released 
into serum containing medium to analyse the effects of 3′-PG-ended DSBs in the absence of TDP1, 
Artemis or both. WT and TDP1-depleted cells showed a similar progression phenotype with only 
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a minor fraction of cells persisting in G1-phase upon damage. Surprisingly, Artemis-deficient cells 
showed a considerable delay in cell-cycle progression such that a significant fraction of cells still 
remained arrested in G1-phase. However, an additional depletion of TDP1 in these cells rescued 
this delay such that the Artemis-/-•shTDP1#2 #2 cells progressed much faster that the Artemis-/- 
single mutants (Fig. 4-24). These results suggest that loss of Artemis delays progression of cells 
from G1 to S phase presumably due to residual un-rejoined breaks. Moreover, loss of TDP1 does 
not cause a delay in progression from G1-S and in fact, rescues the delay observed in Artemis-
deficient cells, TDP1 may play a critical role in the G1-S checkpoint in the presence of 3′-
phosphoglycolate-ended DSBs.  
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Figure 4-22: G1-S Cell Cycle Progression in HCT116 cells 
Cells were synchronized in G0/G1 phase by serum starving for 96 hours. Following serum-
starvation cells were released in serum and cell cycle profiles were analyzed at the indicated 
time points by FACS.  Representative FACS histogram plots showing the percentage of cells in 
each phase of the cell cycle were prepared using ModFit LT software. Horizontal axis depicts 
the DNA-content. A minimum of 30,000 events were collected for each sample.  
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Figure 4-23: G1-S cell cycle progression followed by G2/M arrest in HCT116 cells in the 
presence of Nocodazole 
Following serum-starvation cells were released in serum containing 100 ng/mL nocodazole and 
cell cycle profiles were analyzed at the indicated time points by FACS. plots showing the 
percentage of cells in each phase of the cell cycle were prepared using ModFit LT software. A 
minimum of 30,000 events were collected for each sample.  
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Figure 4-24: G1-S cell cycle progression upon DSB induction by NCS in HCT116 cells. 
Cells were synchronized in G0/G1 phase by serum starving for 96 hours. Following serum-
starvation cells were treated with 2 nM NCS for 6 hours, then released in serum and cell cycle 
profiles were analyzed at the indicated time points by FACS.  Plots showing the percentage of 
cells in each phase of the cell cycle were prepared using ModFit LT software. A minimum of 
30,000 events were collected for each sample.  
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4.8 Interplay between TDP1/Artemis with the DNA damage response proteins PARP1 and 
ATM.  
Poly (ADP)-Ribose Polymerase (PARP) family of proteins are key early responders to 
DNA damage (Liu, Vyas, Kassab, Singh, & Yu, 2017). Upon DSB induction (and SSBs or base 
damage), PARP1 poly (ADP)-ribosylates chromatin and facilitates its opening up that enables 
access to critical DNA repair proteins (O'Connor, 2015). In addition, PARP1 also PARylates 
several other DNA repair factors, though to be necessary for their recruitment at damaged sites 
(Morales et al., 2014). In one such example, TDP1 and PARP1 have been shown to be epistatic 
for the repair of CPT-induced TopI-DNA lesions and TDP1 is poly (ADP)-ribosylated by PARP1 
in this pathway (Das et al., 2014). However, a recent study demonstrated a lack of apparent 
epistasis between TDP1 and PARP1 for the repair of sapacitabine, a chain-terminating nucleoside 
analogs (CTNA) (Abo et al., 2017). This suggests that a differential mechanism exists that allows 
PARP1 to modulate TDP1’s function in response to some types of modified ends but not others. 
Additionally, PARP1 is a key component in the alternative non-homologous end joining (A-NHEJ) 
pathway for the repair of DNA DSBs (Mansour, Rhein, & Dahm-Daphi, 2010). Thus, to 
investigate the functional interaction between TDP1, Artemis and PARP1 for the repair of NCS-
induced 3′-PG terminated DSBs, clonogenic survival assays were performed using the PARP 
inhibitor, AZD-2281 (Olaparib). Unlike WT cells, all the mutants showed an increase in sensitivity 
to NCS upon PARP inhibition (Fig. 4-25) suggesting that TDP1 and Artemis are not epistatic with 
PARP1 but are involved in a pathway parallel to the PARP1-dependent repair of NCS-induced 3′-
PG terminated DSBs. 
ATM kinase is a critical DSB repair protein that phosphorylates a plethora of substrates 
facilitating DSB repair (Blackford & Jackson, 2017). ATM and Artemis are epistatic for the repair 
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of a subset of IR-induced DSBs (Riballo et al., 2004). On the other hand, ATM phosphorylates 
TDP1 for its optimal function at camptothecin-induced breaks (Das et al., 2009). Thus, to 
investigate the role of ATM in the epistasis between Artemis and TDP1, clonogenic survival assays 
were performed using NCS in the presence of an ATM inhibitor KU-60019.  WT cells showed an 
increased sensitivity to NCS upon ATM inhibition suggesting an important role for ATM in the 
repair of 3′-PG DSBs (Fig. 4-26).  Additional TDP1-depletion in these cells enhanced the 
sensitivity even further suggesting that ATM and TDP1 are involved in parallel pathways for the 
repair of NCS-induced DSBs (Fig. 4-26A).  Interestingly, compared to ATM-inhibited WT cells, 
inhibition of ATM in Artemis-/- single and Artemis-/-•shTDP1#2 double mutants led to an increase 
in sensitivity only at high doses of NCS (Fig. 4-26B, C).   
Thus, taken together, these data indicate that TDP1 and Artemis perform both 
complementary and parallel functions in human DNA DSB repair. 
 
 
 
 
 
 
 
 98 
 
 
Figure 4-25: Artemis and TDP1 function in parallel with PARP1 in response to NCS-induced 
DSBs.  
Clonogenic survival assays were performed on isogenic HCT116 WT, TDP1-deficient, Artemis-
deficient, and TDP1/Artemis double-deficient cells treated with NCS in the presence of Olaparib. 
Error bars represent SEM. n=4. 
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Figure 4-26: TDP1 and Artemis function in parallel to ATM in response to NCS-induced 
DSBs. 
Clonogenic survival assays were performed on isogenic HCT116 WT, TDP1-deficient, Artemis-
deficient, and TDP1/Artemis double-deficient cells treated with NCS in the presence of ATM 
inhibitor, Ku-60019. Error bars represent SEM. n=4. 
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4.9 PNKP-deficient cells display enhanced hypersensitivity to NCS 
Polynucleotide Kinase/ Phosphatase is a bifunctional enzyme that processes 3′-phosphates 
and 5′-hydroxyl moieties on the DNA (Weinfeld et al., 2011). To investigate the biological 
significance of PNKP in response to these modification, PNKP was knocked out in HCT116 and 
HeLa cells in the lab of Dr. Michael Weinfeld, University of Alberta. Absence of PNKP in 
HCT116 cells was confirmed by a western blotting experiment. PNKP levels were too low to be 
detected and hence, cyto-nuclear fractionation was performed. A band corresponding to PNKP 
was observed in WT nuclear extract that was lacking in PNKP-/- nuclear extract (Fig. 4-27).  
Previously, it has been shown that shRNA-mediated knockdown of PNKP in A549 lung 
carcinoma cells conferred significant sensitivity to radiation and NCS (Rasouli-Nia, Karimi-
Busheri, & Weinfeld, 2004; Segal-Raz et al., 2011). To more clearly evaluate the cytotoxicity of 
3′-phosphates in the absence of PNKP, clonogenic survival assays were performed in HCT116 as 
well as HeLa cells. PNKP-deficient derivatives of HCT116 and HeLa cells showed enhanced 
sensitivity to both radiation and NCS (Fig. 4-28). In HCT116 cells, PNKP-/- cells were 
considerably more sensitive to NCS, which specifically induces DSBs bearing protruding 3′-
phosphate-terminated DSBs (DMF = 2.5) than to radiation (DMF = 1.5), suggesting that PNKP 
deficiency confers a specific sensitivity to 3′-phosphate-terminated DSBs, consistent with a 
possible deficiency in processing and repair of such lesions.  However, in HeLa cells PNKP-/-/- 
were equally as sensitive to NCS as to radiation (DMF = 1.37), suggesting the presence of more 
robust alternative PNKP-independent DSB repair pathway(s) in HeLa cells than in HCT116. 
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Figure 4-27: Absence of PNKP in nuclear extracts of PNKP-/- HCT116 cells. 
Lack of detectable PNKP in PNKP-/- HCT116 nuclear extracts as probed with an N-terminal 
H101 antibody. A non-specific band at ~ 90 kDa serves as a loading control. rPNKP=50 ng His-
tagged recombinant human PNKP. Vinculin is used as a fractionation control observed only in 
the cytoplasmic fraction.  
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Figure 4-28: PNKP-deficient cells are hypersensitive to NCS and radiation 
Clonogenic survival assays were performed on isogenic HCT116 WT and PNKP-/- cells (A & C) 
as well as HeLa WT and PNKP-/-/- cells (B & D) treated with NCS (A,B) or radiation (C,D). 
Error bars represent SEM. n=3. 
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4.10 Interplay between PNKP and other DNA repair factors 
PNKP is phosphorylated at S114 and S126 by ATM and DNA-PK in response to DSB 
production and S114A/S126A phosphomutant PNKP proteins show decreased 3′-phosphatase 
activity (Segal-Raz et al., 2011). To examine the interplay between PNKP and the DNA damage 
response to NCS, survival of HCT116 WT and PNKP-/- cells was assessed following treatment 
with NCS in the presence of an inhibitor of DNA-PK, ATM kinase, or both.  DNA-PK is a critical 
factor in NHEJ (Jette & Lees-Miller, 2015), while ATM is important for DSB repair by 
homologous recombination as well as for repair of a subset of DSBs by NHEJ (Beucher et al., 
2009; Kocher et al., 2012; Riballo et al., 2004). NU7441 (DNA-PKi) and KU60019 (ATMi) 
equally sensitized WT HCT116 cells, although at the highest NCS concentration, ATMi was more 
potent (Fig. 4-29).  Intriguingly, at low NCS concentrations, each inhibitor was more deleterious 
to survival than was PNKP deficiency, but at the highest concentration, PNKP deficiency was 
more deleterious than the inhibitors, either alone or in combination.  Furthermore, at high levels 
of damage, DNA-PKi had almost no effect on survival of PNKP-/- cells (Fig. 4-29).  These results 
are consistent with the presence of some alternative process or enzyme that can substitute for 
PNKP in NHEJ, but that saturates at very low levels of damage.  Thus, in severely damaged cells, 
repair of NCS-induced DSBs by NHEJ becomes almost completely dependent on PNKP, so that 
DNA-PKi has little effect on PNKP-/- survival.  In the presence of low-level damage, DSBs would 
be repaired by NHEJ despite PNKP deficiency, so that DNA-PKi markedly reduces survival of 
PNKP-/- cells. The additive effects of ATMi and PNKP deficiency on survival are likely to result 
from ATM’s role in DSB repair by homologous recombination, which does not require PNKP 
(Karimi-Busheri, Rasouli-Nia, Allalunis-Turner, & Weinfeld, 2007). 
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Poly(ADP-ribose) polymerase (PARP) adds poly(ADP-ribose) chains to a variety of 
nuclear proteins when DNA is damaged (Rouleau et al., 2010), and is essential for efficient SSB 
repair, as well as for an alternative Ku-independent end joining pathway involving XRCC1, DNA 
ligase III and DNA polymerase theta (Audebert, Salles, & Calsou, 2004; Black, Kashkina, Kent, 
& Pomerantz, 2016; Wood & Doublie, 2016).  In most genetic backgrounds, PARP inhibitors 
confer a replication-dependent radiosensitivity by inhibiting SSB repair and by inappropriately 
channeling the resulting single-ended DSBs into NHEJ (Patel, Sarkaria, & Kaufmann, 2011). 
However, radiosensitivity can be replication-independent when Ku-dependent NHEJ is 
compromised (Hochegger et al., 2006).  Previous work showed that HCT116 cells were 
radiosensitized by the PARP inhibitor Olaparib (Alotaibi et al., 2016; Shelton et al., 2013). 
However, in the current study, Olaparib did not sensitize HCT116 WT cells to NCS, suggesting 
that the relatively small number of NCS-induced SSBs do not contribute significantly to 
cytotoxicity even when PARP is inhibited.  Furthermore, neither Olaparib nor Veliparib further 
sensitized PNKP-/- cells (Fig. 4-29), despite showing clear inhibition of Poly (ADP)-Ribosylation 
in these cells (Fig. 4-30). This result is consistent with reports that PNKP is involved in end joining 
by both Ku-dependent NHEJ (Karimi-Busheri et al., 2007) and PARP-dependent Alt-NHEJ 
(Audebert, Salles, Weinfeld, & Calsou, 2006).  Thus, both repair systems are already compromised 
in PNKP-/- cells, so that blocking Alt-NHEJ with a PARP inhibitor would be expected to have 
little, if any effect. 
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Figure 4-29: Interplay between PNKP and ATM, DNA-PK and PARP1 in response to NCS-
induced DSBs 
Clonogenic survival assays were performed on isogenic HCT116 WT and PNKP-/-/- cells treated 
with NCS in the presence of inhibitors of ATM (A,C), DNA-PK (B,C) or PARP (D). Error bars 
represent SEM. n=3. 
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Figure 4-30: Confirmation of PARP inhibition using western blotting 
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4.10 PNKP is required for rejoining of 3′-P ended DSBs in cells.  
To directly investigate whether the hypersensitivity shown by the mutants to NCS was 
attributable to a defect in repairing 3′-phosphate-ended DSBs, measurements of NCS-induced 
DSBs in cells, detected as 53BP1 foci, were performed.  Serum-starved G1/G0 cells were used to 
specifically analyze DSB repair by NHEJ while avoiding spontaneous focus formation at stalled 
replication forks.  As shown in Fig. 4-31, there were about twice as many residual DSBs in PNKP-
deficient as in WT HCT116 cells at 4 and 8 hr after NCS treatment.  This result is consistent with 
a model wherein increased persistence of 3′-phosphate termini due to lack of PNKP interferes with 
efficient DSB rejoining. 
Since PNKP is critical for the removal of 3′-P from DSB ends during NHEJ and loss of 
PNKP significantly hampers DSB rejoining via NHEJ, we asked whether PNKP-deficient cells 
increase the use of Homologous Recombination for repairing these DSBs. Rad51 foci were 
analysed as HR markers in HCT116 WT and PNKP-/- cells in conjunction with 53BP1 after NCS 
treatment since Rad51 foci indicate commitment to HR (Bunting et al., 2012; Krejci, Altmannova, 
Spirek, & Zhao, 2012; Tarsounas, Davies, & West, 2003). In WT cells, Rad51 foci increased 
slightly by 4 hours and remained steady over a period of 12 hours suggesting that in WT cells, 
majority of breaks are repaired by NHEJ requiring PNKP. In PNKP-/- cells, increase in Rad51 foci 
was similar to WT at 4 hours (Fig. 4-32). However, their number kept increasing over a period of 
12 hours, suggesting that in the absence of PNKP, cells resort to using HR for the repair of these 
3′-phosphate ended DSBs. Interestingly, it was observed that although Rad51 and 53BP1 
colocalize, 53BP1 appears to moves to the periphery allowing HR to proceed, presumably prior to 
resection initiation ultimately allowing Rad51 to load onto the ssDNA filaments and carry out the 
homology search (Fig. 4-31A).  
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Figure 4-31: PNKP-deficient cells show a defect in 3′-P DSB rejoining 
53BP1 foci were scored in serum-starved cells treated with 4 nM NCS for 1 hr and results 
plotted as number of 53BP1 foci per nucleus. Foci were counted using ImageJ whereas the 
counting of nuclei was done manually. Error bars represent SEM for n=4.  
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Figure 4-32: PNKP-/- cells show increased HR compared to WT cells for repairing 3′-P ended 
DSBs 
53BP1 and Rad51 foci were scored at the indicated times after 4 nM NCS treatment for 1 hour. 0 
hr indicates untreated sample. (A) Colocalization of Rad51 and 53BP1 foci in one representative 
nucleus in both WT and PNKP-/- cells. (B) Quantification of the respective markers. Left vertical 
axis indicates 53BP1 foci per nucleus represented by the bar graphs. Right vertical axis 
represents Rad51 foci per nucleus represented by the line graphs. Rad51 and 53BP1 foci were 
together analyzed only in 1 experiment.   
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5. DISCUSSION 
 
 
 
Cytotoxic DNA damaging agents including ionizing radiation and radiomimetic natural 
compounds like NCS, CAL and bleomycin induce terminally-occluded DNA DSBs by free-radical 
mechanisms (Menon & Povirk, 2016). Although many 3′-blocked termini are unstable and 
spontaneously break down to 3′-phosphates, 3′-phosphoglycolates formed by fragmentation of the 
deoxyribose by oxidation of the C-4′ position are stable and persistent (Povirk, 1996; Povirk, 
2012). Gap-filling DNA polymerases and DNA ligases require 3′-hydroxyl DNA ends to 
efficiently add nucleotides and perform end ligation respectively, and therefore the resolution of a 
3′-phosphoglycolate to a 3′-hydroxyl is an essential step in the repair of these DSBs. It is therefore 
not surprising that mammalian cells have evolved several enzymes — including TDP1, APE1 and 
Artemis — for such resolution (Zhou et al., 2005). 
In the current study, NCS and CAL were used to investigate the role of TDP1 in the repair of 
3′-phosphoglycolate DSBs.  In contrast to radiation-induced DSBs which are heterogeneous and 
bear 3′-phosphoglycolate only on 10% of the total sugar oxidation products (B. Chen et al., 2007), 
about one in every four DSBs induced by CAL and NCS bear a 3′-phosphoglycolate, making these 
antitumor antibiotics more informative than IR in studying the repair of 3′-phosphoglycolate-DSBs 
(Povirk, 1996).  Supporting established evidence of TDP1’s critical role in 3′-phosphoglycolate 
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removal, TDP1-deficient cells were hypersensitive to both NCS and CAL (Hawkins et al., 2009; 
Inamdar et al., 2002; Zhou et al., 2009).   
Scientists have used the principle of epistasis to delineate genes functioning in common or 
parallel DNA repair pathways (Glassner & Mortimer, 1994; Jensen, Ozes, Kim, Estep, & 
Kowalczykowski, 2013; Symington, 2002). According to the principle of epistasis, if the 
phenotypic impact of simultaneous deletion of 2 genes is equal in severity to that of the loss of 
function of individual genes, it may indicate that the genes function within a common pathway, 
possibly performing different roles in it (Ishii & Inoue, 1989). On the other hand, if the double 
deletion is phenotypically more severe than the individual deletions, it may result from the loss of 
compensatory repair pathways (Batenchuk, Tepliakova, & Kaern, 2010).  
Elimination of Artemis, a DSB end-trimming nuclease that can also resolve 3′-
phosphoglycolates (Povirk et al., 2007), likewise sensitized cells to NCS. Surprisingly, however, 
the toxicity of 3′-phosphoglycolate DSBs observed in cells simultaneously deficient in Artemis 
and TDP1 compared to cells with individual deficiencies in these genes was similar, indicating 
that these two proteins function in the same DSB repair pathway.  Furthermore, as DSBs in G1-
phase are repaired almost exclusively by NHEJ (Biehs et al., 2017), the epistasis between Artemis 
and TDP1 in cells synchronized in the G1-phase suggests an involvement of these two proteins in 
NHEJ. In addition, the increased toxicity of 3′-phosphoglycolate DSBs upon DNA-PK inhibition 
was not further enhanced by an additional deficiency in TDP1, Artemis or both.  Thus, when C-
NHEJ is suppressed, TDP1 and Artemis no longer contribute to survival after NCS treatment.  
Taken together, these data strongly support a functional involvement of Artemis and TDP1 in C-
NHEJ for the repair of NCS-induced 3′-phosphoglycolate DSBs. 
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Figure 5-1: Model of the epistasis between Artemis and TDP1 
NCS treatment leads to the production of double-strand breaks in the DNA having 3′-
phosphoglycolate ends. In the presence of functional Artemis and TDP1, there is accurate DSB 
rejoining promoting cell survival. In the absence of Artemis, a fraction of DSBs remain 
unrejoined causing a survival defect. On the other hand, in the absence of TDP1, DSB ends are 
misjoined causing translocations and decrease in survival. Thus, although the two proteins 
function in the same pathway, loss of these proteins confers disparate phenotypes.   
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Figure 5-2: Model representing the DSB repair pathways and proteins analyzed in the study.  
TDP1 and Artemis are in the same pathway for the repair of NCS-induced DSBs whereas ATM 
and PARP function in parallel. In the absence of TDP1, the breaks are shuttled to a more error-
prone repair pathway regulated by the kinase activity of DNA-PK leading to misjoining of DSB 
ends. It is possible that the PARP1-dependent end joining pathway is actually the error-prone 
repair pathway promoting misjoining as has been previously shown.  
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The sensitivity of HEK293 TDP1-/- cells to NCS was only partially rescued by 
complementing with recombinant TDP1 such that the complemented cells showed intermediate 
survival to WT and TDP1-/- cells to NCS. This recombinant protein expressed in the 
complemented cell line has an N-terminal Flag tag. Since the N-terminal region of TDP1 is 
important for its recruitment to DSB sites, it is possible that this Flag tag interferes with the 
recruitment of TDP1 to DSB sites, thereby causing a partial rescue. This result is in agreement 
with previous reports where in one study, recombinant TDP1 only partially rescued the sensitivity 
of TDP1-/- DT40 avian cells to ionizing radiation-induced DSBs (Abo et al., 2017). Another recent 
study reported that sensitivity HEK293 TDP1-/- cells to camptothecin could be rescued at low, but 
not high doses of CPT by ectopically expressing WT TDP1 (J. Li et al., 2017).   
The unexpected epistatic interplay between Artemis and TDP1 in survival of NCS treatment 
suggests that these two proteins perform non-overlapping roles in the repair of NCS-induced 
DSBs. This further implies that either Artemis or TDP1, but not both, are involved in the enzymatic 
processing of 3′-phosphoglycolates. Considering the well-documented role of TDP1 in clean 3′-
phosphoglycolate removal, one likely possibility is that, upon NCS/CAL-induced DSB formation, 
the overhanging 3′-phosphoglycolate on one end of the DSB is a substrate for TDP1 whereas 
Artemis is required for removing the 5′-aldehyde formed on the other strand.  Since the other end 
bears a 3′-phosphate which is the canonical substrate of PNKP, a critical end processing enzyme 
that interacts with the X-ray cross-complementing 4 (XRCC4)•LigaseIV complex in the context 
of C-NHEJ (Aceytuno et al., 2017), it is unlikely that either TDP1 or Artemis processes the 3′-
phosphate ends.  Alternatively, it can be surmised that if Artemis is important for 3′-
phosphoglycolate end trimming via C-NHEJ, TDP1 might be playing a structural role in this 
pathway.  Consistent with this possibility, TDP1 physically interacts with XLF and Ku70/80, key 
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proteins in the C-NHEJ pathway and stimulates binding of XLF and Ku70/80 to DNA (Heo et al., 
2015).  In this manner, a TDP1 deficiency would abrogate C-NHEJ-mediated DSB repair and the 
simultaneous absence of Artemis would have no additional effect. On the other hand, Artemis has 
been proposed to play a role in DSB repair pathway choice, directing breaks into C-NHEJ when 
appropriate (J. Wang et al., 2014).  Loss of this function could lead to suboptimal repair regardless 
of whether 3′-phosphoglycolate termini are resolved.  In the future, it will be interesting to explore 
these possibilities by tracking the processing of 3′-phosphoglycolate ends using ligation-mediated 
PCR (Akopiants et al., 2014) or complementing our mutant cell lines with either an endonuclease-
deficient Artemis or a phosphodiesterase-deficient TDP1, respectively (J. Li et al., 2017; 
Mohapatra et al., 2011). 
It is not uncommon for epistatic mutants with similar sensitivity to DNA damaging agents to 
show functional heterogeneity, evident from studies conducted on mutants belonging to the Rad52 
epistasis group in S. cerevisiae (Petrini, Bressan, & Yao, 1997). Although scRad52, scRad51, 
scRad50 and scMre11 all are epistatic for IR sensitivity, the recombination phenotypes in mutants 
of these proteins are different. For example, meiosis-specific DSBs are formed by scMre11, 
scRad50 and scXrs2 to initiate recombination. These DSBs are formed in the scRad51 and 
scRad52 mutants, but the completion of recombination is severely impaired suggesting that these 
gene products are required at different stages of the recombination process (Petrini et al., 1997). 
Similarly, results from the current study show that although TDP1 and Artemis are epistatic for 3′-
PG ended DSBs, they likely perform at different stages in the repair process.  
In contrast to NCS and CAL, the repair of IR-induced breaks seems to require either TDP1 or 
Artemis as cells deficient in both are more radiosensitive than cells deficient in either individual 
protein.  On one hand, it is known that the endonuclease function of Artemis is required in IR-
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induced DSB repair (Mohapatra et al., 2011) and that Artemis is required for the repair of a subset 
of DSBs formed in heterochromatin (Beucher et al., 2009; Riballo et al., 2004).  On the other hand, 
TDP1-mutant SCAN1 cells are defective in IR-induced SSB repair (El-Khamisy et al., 2007).  Due 
to the heterogeneous nature of damage induced by radiation, TDP1 may thus be required for the 
repair of IR-induced SSBs while Artemis repairs the subset of DSBs in the heterochromatin.  
Accordingly, simultaneous absence of both proteins makes the cells more radiosensitive than their 
individual absence.  Another possible basis for the positive epistasis is that phosphoglycolates 
formed on short overhangs (<3 bases) might be repaired by TDP1 whereas longer overhangs — 
due to clustered damage — might require Artemis (Povirk et al., 2007). 
Another unanticipated finding was the apparent lack of a DSB rejoining defect in TDP1-
depleted cells, despite their hypersensitivity to NCS.  Assays of 53BP1 foci, a surrogate marker of 
unrepaired DSBs, indicated that these repair foci disappear with similar kinetics in WT and TDP1-
depleted cells. Although this assay is standard for measuring the fraction of DSBs that remain 
unrejoined, it is limited by its inability to differentiate between DSB ends that are correctly 
rejoined, and DSB ends that are mis-joined to ends of other DSBs in the cell.  Thus, it was 
hypothesized that TDP1-depleted cells might be hypersensitive to NCS due to inaccurate DSB 
joining and consequent formation of lethal chromosome aberrations.  Indeed, C-FISH experiments 
demonstrated a significant increase in the number of dicentric chromosomes upon TDP1 depletion 
suggesting that, in these cells, many 3′-phosphoglycolate DSBs are mis-joined.  Conversely, in 
agreement with a DSB rejoining defect observed in the 53BP1 assay, Artemis-deficient cells 
showed an increase in the level of acentric chromosomal fragments, representing unjoined DSBs, 
but not in dicentrics.  The increased incidence of dicentrics in TDP1-depleted cells is reminiscent 
of increased dicentrics observed in TDP1-mutant SCAN1 cells following treatment with CAL.  
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The conclusion that TDP1 is involved predominately in mis-joining is consistent with a recent 
study that demonstrated that TDP1 is required for efficient C-NHEJ in human cells (J. Li et al., 
2017).  In this study, a deficiency of TDP1 reduced the fidelity of end joining with an increase in 
insertions at repair junctions of I-SceI-induced DSBs, which could be completely restored by WT 
TDP1 but only partially by catalytically-inactive TDP1H263A.  These insertions at DSB sites could 
reflect mis-joining of persistent DSB ends to small pieces of unrelated DNA.  Even in yeast, in the 
absence of TDP1, restriction enzyme-induced DSBs are inaccurately repaired with an increase in 
C-NHEJ-dependent insertions possibly via the mutagenic polymerase, Pol IV (Bahmed et al., 
2010). 
In contrast to the recent findings that TDP1 knockout in HEK293 cells caused a decrease in 
end joining efficiency of I-SceI induced-DSBs, results in the current study do not show a DSB 
rejoining defect in TDP1-depleted cells. Possible explanations for this discrepancy include the 
difference in the nature and the number of breaks as well as the use of different cellular systems. 
DSBs induced by I-SceI contain unmodified, 3′-hydroxyl ends compared to those induced by NCS.  
In the absence of TDP1, the terminal nucleoside on the restriction enzyme-induced DSB ends 
would not be removed leading to insertions by mutagenic polymerases decreasing the overall end 
joining efficiency. Conversely, the 3′-modification in NCS-induced DSBs precludes the activity 
of these polymerases averting aberrant insertions and thus may prevent a DSB rejoining defect. 
Moreover, the use of different cellular systems impedes direct comparison of the results between 
the two studies. 
In the context of C-NHEJ, inhibition of DNA-PK blocks its auto-phosphorylation and 
prevents its inward translocation from DSB ends and thereby restricts access of other end-
processing enzymes to the DSB end.  The finding that DNA-PK inhibition rescues mis-joining in 
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TDP1-depleted cells (both shTDP1#18 and Artemis-/-•shTDP1#2) to levels seen in TDP1-
proficient cells suggests that a TDP1 deficiency renders the C-NHEJ pathway more error-prone, 
rather than invoking a separate backup pathway.  Although Artemis-mediated resection-dependent 
C-NHEJ can cause translocations (Biehs et al., 2017), in the current study, dicentric chromosomes 
were still persistent in Artemis-/-•shTDP1#2 cells, refuting the role of Artemis in this error-prone 
mis-joining. The Alternative end-joining protein, C-terminal interacting protein (CtIP) is another 
possible candidate mediating error-prone joining in the absence of TDP1.  Indeed, CtIP functions 
in parallel to TDP1 for the repair of Top1-induced SSBs and methyl methane sulfonate (MMS)-
induced lesions (Murai et al., 2012).  Moreover, CtIP is phosphorylated by Polo-like kinase 3 
(Plk3) and promotes ionizing radiation-induced chromosomal translocations (Barton et al., 2014; 
Makharashvili & Paull, 2015). Depletion of CtIP has also been shown to decrease translocations 
in mouse cells (Helmink et al., 2011). Plk3 is phosphorylated by ATM in response to DNA-damage 
which is abrogated by caffeine treatment (Bahassi el et al., 2002). Although there is no evidence 
yet of CtIP being a target of DNA-PK and since ATM and DNA-PK have redundant functions, it 
remains to be investigated whether in the absence of ATM, DNA-PK can phosphorylate Plk3 
which in turn would activate CtIP-mediated end resection promoting translocations. Then, 
inhibition of DNA-PK would reduce the translocations as observed in the current study. Taken 
together, our results indicate that TDP1 is required for accurate joining of DSB ends and, in its 
absence, a more error-prone DNA-PK-dependent process inaccurately repairs NCS-induced 
DSBs. 
Another interesting finding from the current study was the effect of the absence of TDP1 and 
Artemis on cell cycle progression in the presence of 3′-phosphoglycolate-ended DSBs. It is quite 
surprising that the role of TDP1 in cell cycle regulation, or its lack thereof, has never been 
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published. A few studies have investigated the role of Artemis in cell cycle (Kurosawa & Adachi, 
2010). Artemis is phosphorylated by ATM and in response to ionizing radiation, is needed for 
recovery from the G2/M cell cycle checkpoint by regulation of Cdk1-Cyclin B (Geng et al., 2007). 
Artemis was shown to be phosphorylated by ATR at Ser516 and Ser645 in response to replication 
stress leading to ubiquitination and degradation of cyclin E, thus promoting recovery from S-phase 
checkpoint (H. Wang et al., 2009). The finding that Artemis deficiency prolongs DSB-induced 
G1-arest in HCT116 cells has been shown for the first time and was expected as in the absence of 
Artemis, cells with increased proportion of un-rejoined breaks would be prevented from entering 
S-phase. Surprisingly, additional depletion of TDP1 released this DSB-induced G1-block with 
higher percent of Artemis-/-•shTDP1#2 cells in the S-phase compared to the Artemis-/- single 
mutants. One hypothesis explaining this discrepancy is the possibility of TDP1 being important 
for the DSB-induced G1-S checkpoint. In that scenario, the G1-arrest brought about by Artemis 
deficiency would be abrogated by an additional depletion of TDP1 as it would prevent the 
checkpoint from functioning and cells with unrepaired breaks would progress through the cell 
cycle accumulating damage, ultimately showing decreased survival. It would be interesting in 
future to investigate whether this observation holds true and if yes, the potential implications of 
TDP1 being a part of the G1-S checkpoint in therapy.  
Survival assays performed to investigate the relationship between TDP1 and Artemis with 
ATM strongly suggest that ATM is critical for the repair of 3′-phosphoglycolate DSBs as WT cells 
show enhanced sensitivity to NCS upon ATM inhibition. ATM and TDP1 appear to function in 
parallel pathways for the repair of 3′-phosphoglycolate DSBs since TDP1-depleted cells showed 
increased sensitivity to NCS upon ATM inhibition compared to ATM inhibition in WT cells. More 
interestingly, compared to ATM inhibition in WT, ATM inhibition in Artemis-deficient cells (Art-
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/- single mutants and Artemis-/-•shTDP1#2 double mutants) did not sensitize them further to low 
doses of NCS. One possible explanation for this discrepancy is that, at lower doses of NCS, in the 
absence of ATM, Artemis drives the repair of 3′-phosphoglycolate DSBs towards a TDP1-
dependent repair pathway. In this way, a combined absence of ATM and TDP1 would make the 
cells more sensitive than the absence of the individual proteins as both TDP1-dependent and ATM-
dependent repair of 3′-phosphoglycolate DSBs would be abolished. However, in the absence of 
Artemis, the drive towards TDP1- dependent repair would be lost, allowing 3′-phosphoglycolate 
DSB repair via a backup repair pathway. This backup process would then prevent Artemis 
deficiency upon ATM inhibition from being more deleterious than ATM inhibition alone at low 
doses of NCS. 
In contrast to a previous report showing radiosensitization of HCT116 WT cells by a PARP 
inhibitor (Alotaibi et al., 2016), PARP1 inhibition did not sensitize these cells to NCS.  This 
differential response could be attributed to the type of damage induced by the different agents.  
Since PARP1 is a key protein in base excision repair (BER), PARP1 inhibition upon IR, which 
forms DSBs to SSBs at a ratio of around 1:20 in addition to base damage, would cause 
accumulation of residual SSBs and damaged bases that upon replication would be converted to 
one-ended DSBs (Povirk, 1996).  Due to the higher proportion of DSBs formed by NCS (DSB/SSB 
ratio ~1:5) and the absence of base damage, PARP1 inhibition is less likely to significantly 
sensitize the cells through interference with SSB repair.  The inference that SSBs contribute little 
to NCS cytotoxicity, even in PARP1-inhibited cells, provides further support for the conclusion 
that the NCS sensitivity of shTDP1 knockdown cells reflects a role for TDP1 in DSB repair, not 
its well-documented role in SSB repair.  However, the toxicity of 3′-phosphoglycolate DSBs in 
PARP1-inhibited cells was slightly enhanced by a deficiency of TDP1, Artemis and both. This 
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relationship between PARP1 and TDP1/Artemis is consistent with PARP1-mediated DSB repair 
(i.e., alternative end-joining) acting as a backup for NHEJ in the absence of TDP1 or Artemis. 
Since PNKP is capable of dephosphorylating a variety of single- and double-strand 
substrates including DSB ends (Weinfeld et al., 2011) and is recruited to DSB ends by the core 
NHEJ protein XRCC4 (Aceytuno et al., 2017), a role for PNKP in resolving 3′-phosphate termini 
of free radical-mediated DSBs is highly likely but has never been explicitly demonstrated. In order 
to assess the importance of this function for DSB repair by NHEJ and to examine the fate of 3′-
phosphate-terminated DSBs in the absence of PNKP, the PNKP gene was disrupted in HCT116 
and in HeLa cells using CRISPR/CAS9. This is the first study, to our knowledge, reporting the 
generation of human PNKP knockout cells and suggests that PNKP is not an essential gene.  
Supporting established evidence in the role of PNKP in removing 3′-phosphates on DSBs, 
PNKP-deficient HCT116 and HeLa cells were hypersensitive to both NCS as well as radiation. 
However, compared to HeLa cells, deficiency of PNKP in HCT116 cells was significantly more 
deleterious in response to NCS. As has been mentioned before, HCT116 cells show decreased 
expression of Mre11 (Sacho & Maizels, 2011). For the repair of Top1-induced breaks, PNKP 
functions downstream of TDP1 whereas Mre11 function in parallel to this TDP1-PNKP dependent 
pathway. Thus, deletion of PNKP in these cells potentially abrogates both the pathways possibly 
leading to the increased sensitization of these cells. Although involvement of PNKP in NHEJ, as 
well as radiosensitivity of PNKP knockdown cells had been demonstrated previously, the 
heterogeneous nature of radiation damage, the high ratio of single-strand breaks to DSBs, and the 
involvement of PNKP in multiple repair pathways including SSB repair, complicates interpretation 
of radiosensitivity data. Because NCS induces a much higher proportion of DSBs and all NCS-
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induced DSBs have at least one 3′-phosphate end, the finding that PNKP-deficient HCT116 cells 
are more sensitive to NCS than to radiation strengthens the implication of PNKP in NHEJ.  
The hypersensitivity seen in PNKP-deficient cells correlates with an increased persistence 
and a delayed disappearance of 53BP1 foci, observed as DSB markers. Given the bifunctional 
nature of PNKP, it is unclear whether this DSB rejoining defect seen in PNKP-deficient cells is as 
a result of a loss of its phosphatase activity, its kinase activity or a combination of both. However, 
since NCS-induced DSBs predominantly bear 3′-phosphate groups, it can be inferred that the DSB 
rejoining defect is specifically due to the absence of the phosphatase activity. 5′-hydroxyl DSB 
ends are usually not produced by NCS (Povirk, 1996).  
Survival experiments performed using DNA-PK inhibitor showed that at low 
concentrations, inhibition of DNA-PK further sensitized PNKP-/- cells to NCS. This data suggests 
that, in NHEJ, in the absence of PNKP, a DNA-PK-dependent repair factor can function as backup 
for repairing 3′-phosphate-ended DSBs at low NCS doses. Biochemical experiments performed 
have also shown a clear removal of the 3′-phosphate on model DSB substrates even in the extracts 
of PNKP-deficient cells. The identity of this apparent phosphatase is yet unknown and some 
candidates include Ape1, Mre11, Artemis, Aprataxin and APLF. Mre11 and Artemis are both 
known to trim >1 nucleotides via endonucleolytic trimming and hence, are unlikely to perform the 
clean phosphatase function observed in biochemical assays (Povirk et al., 2007; Sacho & Maizels, 
2011). Although Ape1 has a weak 3′-phosphatase function (Demple & Harrison, 1994), it has not 
been shown to act on 3′-overhangs (Suh, Wilson, & Povirk, 1997). Aprataxin is a good candidate 
that has been shown to possess a clean 3’-phosphatase function (Takahashi et al., 2007). It will be 
interesting to construct double-mutants of PNKP and Aprataxin to study the relationship between 
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these two phosphatases in response to NCS-mediated DNA damage. Moreover, it seems unlikely 
that a broad-specificity phosphatase is performing this function as it is regulated by DNA-PK.  
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6. CONCLUSIONS AND FUTURE PERSPECTIVES 
 
 
 
In conclusion, observations from this dissertation suggest a strong epistasis between 
Artemis and TDP1 for survival against the toxicity of 3′-phosphoglycolate terminated DSBs 
induced by NCS and CAL. Importantly, however, although Artemis and TDP1 are involved in the 
same pathway, they perform non-overlapping functions and thereby, mediate survival through 
different mechanisms. Artemis promotes survival by promoting DSB rejoining, whereas TDP1 
promotes the accurate joining of the DSB ends. The inaccurate joining of 3′-PG DSB ends is 
mediated by the classical Non-Homologous End Joining Pathway as a small molecule inhibitor of 
DNA-PKcs eliminated the TDP1-loss-dependent misjoining. With respect to the role of Artemis 
and TDP1 in cell cycle regulation, Artemis is needed for a recovery from G1 → S cell cycle 
checkpoint upon 3′-PG DSB induction. TDP1 is important for the G1 → S cell cycle checkpoint 
and thus, an additional loss of TDP1 rescues the delayed recovery observed in Artemis-deficient 
cells. PARP1 functions in parallel to both TDP1 and Artemis in repairing 3′-PG DSBs. The 
interplay between ATM, Artemis and TDP1 is dose dependent. In the absence of ATM, TDP1 is 
more important at low concentrations whereas Artemis is critical at higher concentrations.  
Experiments performed in PNKP-deficient cells showed that PNKP is critical for the repair 
of 3′-phosphate-terminated DSBs. The increased cytotoxicity is represented by a lack of 
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3′-phosphate-DSB rejoining. PARP1-dependent repair is a subset of PNKP-dependent repair 
pathways. ATM and PNKP function in parallel for repairing 3′-phosphate-ended DSBs. Despite 
the importance of PNKP, in its absence, a backup repair factor functions in a DNA-PK-
dependent manner at low levels of 3′-phosphate DSBs. However, higher levels of 3′-phosphate 
DSBs require PNKP as this factor gets saturated. 
It is important to note that since HCT116 Artemis-/-TDP1-/- cells were not available for 
the major part of the study and have been recently generated, most of the studies reported in this 
dissertation involve the use of TDP1-depleted cells. It is critical to reproduce the observations 
using these double-knockout cells. The involvement of TDP1 in NHEJ can be further confirmed 
by generating Ligase IV-/- TDP1-/- double mutants and performing these experiments in them. 
These cells will also be critical in understanding the role of NHEJ in misjoining of DSBs in the 
absence of TDP1. 
Although TDP1 and Artemis are epistatic, it is unclear what roles do these proteins play 
at these DSBs. Complementing the deficient cells with endonuclease-deficient Artemis/ 
phosphodiesterase-deficient TDP1 will provide insights into these questions. In addition, a 
ligation mediated PCR assay will be performed to track the processing of NCS-induced modified 
ends in these mutants. Another important experiment that would provide completeness to the 
study will be to investigate this interplay in normal cells as opposed to cancer cells. Along those 
lines, CJ179- hTert Artemis-deficient fibroblasts will be used to eliminate TDP1 and survival 
experiments will be performed to analyze whether the epistasis is prevalent in normal cells. 
Genomic instability is a hallmark of tumorigenesis, but its excess can limit cell survival. 
The nearly pervasive involvement of TDP1/PNKP in DNA repair makes them an attractive 
element for tumor cell sensitization. Indeed, inhibitors of several DNA repair proteins have 
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dominated the limelight in relation to cancer chemotherapy and the work has led to the 
development of the principle of synthetic lethality – largely selective toxicity of an inhibitor 
against tumor cells deficient in parallel repair pathways that are otherwise functional in normal 
cells. However, attempts toward developing potent inhibitors of TDP1 have met with resistance 
as none of the inhibitors have shown cellular activity. Elucidation of regulation of TDP1/PNKP 
and its functional interaction with other DNA repair proteins will add to our understanding of the 
complex web of networks to which DNA repair pathways belong, with the ultimate aim of 
making it easier to develop DNA repair inhibitors, functioning either clinically or in research to 
unravel the myriad DSB repair mechanisms. 
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